Cor Vasa 2022, 64(Suppl. 2):7-86 | DOI: 10.33678/cor.2022.024

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Translation of the document prepared by the Czech Society of Cardiology

Miloš Táborskýa, Josef Kautznerb, Marián Fedorcoa, Karol Čurilac, Hanka Wünschováb, Jan Pyszkoa, Miroslav Novákd, Milan Kozáke, Martin Válekf, Rostislav Polášekg, Patrik Keprta, Milena Kubíčkováh, Jiří Plášekch, Vít Glogeri, Alan Bulavaj, Vlastimil Vančurak, Tomáš Skálaa, Petr Pařízekl, Josef Daněkm
a I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc, Olomouc
b Klinika kardiologie, Institut klinické a experimentální medicíny, Praha
c Kardiologická klinika, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha
d I. interní kardioangiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice u sv. Anny v Brně, Brno
e Interní kardiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno
f II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
g Kardiovaskulární centrum, Krajská nemocnice Liberec, a. s., Liberec
h Kardiologická klinika, Fakulta zdravotnických studií Univerzity J. E. Purkyně v Ústí nad Labem a Krajské zdravotní, a.s., a Masarykova nemocnice v Ústí nad Labem, o. z., Ústí nad Labem
ch Interní a kardiologická klinika, Lékařská fakulta Ostravské univerzity a Fakultní nemocnice Ostrava, Ostrava
i Kardiologické oddělení, Krajská nemocnice Tomáše Bati ve Zlíně, Zlín
j Kardiologické oddělení, Nemocnice České Budějovice, a.s., České Budějovice a Zdravotně sociální fakulta Jihočeské univerzity v Českých Budějovicích, České Budějovice
k Kardiologická klinika, Lékařská fakulta Plzeň, Univerzita Karlova a Fakultní nemocnice Plzeň, Plzeň
l I. interní kardioangiologická klinika, Lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Hradec Králové, Hradec Králové
m Kardiologické oddělení, Interní klinika, 1. lékařská fakulta Univerzity Karlovy a Ústřední vojenská nemocnice, Praha

The chapter is a detailed translation of the updated, 2021 European Society of Cardiology guidelines on cardiac pacing and cardiac resynchronization therapy. It presents a modified classification of bradyarrhythmias considered for cardiac pacing and highlights the importance of precision diagnosis based on the patient's symptomatology. In addition to conventional techniques, the updated version includes, as a novelty, the issue of conduction system pacing as an alternative to cardiac resynchronization therapy. A completely new subsection covers the topic of pacing in patients undergoing transcatheter aortic valve implantation. The indications are clearly specified, with preventive pacing in patients developing bundle branch block no longer recommended. Yet another new concept incorporated into the update is leadless pacing in the "real-world" setting. A section that clinicians will find most useful examines indications for pacing in specific clinical scenarios such as congenital heart disease, pregnancy, postoperative bradycardias, and so on. © 2022 European Society of Cardiology. All rights reserved. Published by the Czech Society of Cardiology.

Keywords: alternate site pacing, atrial fibrillation, bradycardia, cardiac pacing, cardiac resynchronization therapy, complications, conduction system pacing, guidelines, heart failure, pacemaker, pacing indications, pacing in TAVI, syncope, temporary pacing,

Received: March 12, 2022; Accepted: March 12, 2022; Published: April 26, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Táborský M, Kautzner J, Fedorco M, Čurila K, Wünschová H, Pyszko J, et al.. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Translation of the document prepared by the Czech Society of Cardiology. Cor Vasa. 2022;64(Suppl. 2):7-86. doi: 10.33678/cor.2022.024.
Download citation

References

  1. Glikson M, Nielsen JC, Kronborg MB, et al.; ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:3427-3520. Go to original source... Go to PubMed...
  2. Timmis A, Townsend N, Gale C, et al.; ESC Scientific Document Group. European Society of Cardiology: cardiovascular disease statistics 2017. Eur Heart J 2018;39:508-579. Go to original source... Go to PubMed...
  3. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter‑defibrillators: calendar year 2009 - a World Society of Arrhythmia's project. Pacing Clin Electrophysiol 2011;34:1013-1027. Go to original source... Go to PubMed...
  4. Gregoratos G. Permanent pacemakers in older persons. J Am Geriatr Soc 1999;47:1125-1135. Go to original source... Go to PubMed...
  5. Mond HG. The World Survey of Cardiac Pacing and Cardioverter Defibrillators: calendar year 1997. Pacing Clin Electrophysiol 2001;24:869-870. Go to original source... Go to PubMed...
  6. Mond HG. The World Survey of Cardiac Pacing and Cardioverter Defibrillators: calendar year 1997 - Asian Pacific, Middle East, South America, and Canada. Pacing Clin Electrophysiol 2001;24:856-862. Go to original source... Go to PubMed...
  7. Ector H, Rickards AF, Kappenberger L, et al.; Working Group on Cardiac Pacing. The World Survey of Cardiac Pacing and Implantable Cardioverter Defibrillators: calendar year 1997 - Europe. Pacing Clin Electrophysiol 2001;24:863-868. Go to original source... Go to PubMed...
  8. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol 2008;31:1202-1212. Go to original source... Go to PubMed...
  9. Bradshaw PJ, Stobie P, Knuiman MW, et al. Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population. Open Heart 2014;1:e000177. Go to original source... Go to PubMed...
  10. Johansson BW. Complete heart block. A clinical, hemodynamic and pharmacological study in patients with and without an artificial pacemaker. Acta Med Scand Suppl 1966;451:1-127. Go to PubMed...
  11. Edhag O. Long-term cardiac pacing. Experience of fixed-rate pacing with an endocardial electrode in 260 patients. Acta Med Scand Suppl 1969;502:9-110. Go to PubMed...
  12. Edhag O, Swahn A. Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers. A long-term follow-up study of 101 patients. Acta Med Scand 1976;200:457-463. Go to original source... Go to PubMed...
  13. Friedberg CK, Donoso E, Stein WG. Nonsurgical acquired heart block. Ann N Y Acad Sci 1964;111:835-847. Go to original source... Go to PubMed...
  14. Shaw DB, Holman RR, Gowers JI. Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J 1980;280:139-141. Go to original source... Go to PubMed...
  15. Alboni P, Menozzi C, Brignole M, et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial. Circulation 1997;96:260-266. Go to original source... Go to PubMed...
  16. Sutton R, Kenny RA. The natural history of sick sinus syndrome. Pacing Clin Electrophysiol 1986;9:1110-1114. Go to original source... Go to PubMed...
  17. Hofer S, Anelli-Monti M, Berger T, et al. Psychometric properties of an established heart disease specific health- -related quality of life questionnaire for pacemaker patients. Qual Life Res 2005;14:1937-1942. Go to original source... Go to PubMed...
  18. Fleischmann KE, Orav EJ, Lamas GA, et al. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm 2006;3:653-659. Go to original source... Go to PubMed...
  19. Lopez-Jimenez F, Goldman L, Orav EJ, et al. Health values before and after pacemaker implantation. Am Heart J 2002;144:687-692. Go to original source...
  20. Newman D, Lau C, Tang AS, et al.; CTOPP Investigators. Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing. Am Heart J 2003;145:430-437. Go to original source... Go to PubMed...
  21. Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 1998;338:1097-1104. Go to original source... Go to PubMed...
  22. Lamas GA, Lee KL, Sweeney MO, et al. Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual‑chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854-1862. Go to original source... Go to PubMed...
  23. Tjong FVY, Beurskens NEG, de Groot JR, e al.; MICRA Investigators. Health-related quality of life impact of a transcatheter pacing system. J Cardiovasc Electrophysiol 2018;29:1697-1704. Go to original source... Go to PubMed...
  24. Goette A, Kalman JM, Aguinaga L, et al.; Document Reviewers. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace 2016;18:1455-1490. Go to original source... Go to PubMed...
  25. Kottkamp H. Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol 2012;23:797-799. Go to original source... Go to PubMed...
  26. Sodeck GH, Domanovits H, Meron G, et al. Compromising bradycardia: management in the emergency department. Resuscitation 2007;73:96-102. Go to original source... Go to PubMed...
  27. El-Sherif N, Jalife J. Paroxysmal atrioventricular block: are phase 3 and phase 4 block mechanisms or misnomers? Heart Rhythm 2009;6:1514-1521. Go to original source... Go to PubMed...
  28. Lee S, Wellens HJ, Josephson ME. Paroxysmal atrioventricular block. Heart Rhythm 2009;6:1229-1234. Go to original source... Go to PubMed...
  29. Narula OS, Samet P, Javier RP. Significance of the sinus-node recovery time. Circulation 1972;45:140-158. Go to original source... Go to PubMed...
  30. Alboni P, Menozzi C, Brignole M, et al. An abnormal neural reflex plays a role in causing syncope in sinus bradycardia. J Am Coll Cardiol 1993;22:1130-1134. Go to original source... Go to PubMed...
  31. Brignole M, Menozzi C, Gianfranchi L, et al. Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 1991;68:1032-1036. Go to original source... Go to PubMed...
  32. Brignole M, Deharo JC, De Roy L, et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol 2011;58:167-173. Go to original source... Go to PubMed...
  33. Deharo JC, Brignole M, Guieu R. Adenosine hypersensitivity and atrioventricular block. Herzschrittmacherther Elektrophysiol 2018;29:166-170. Go to original source... Go to PubMed...
  34. Brignole M, Auricchio A, Baron-Esquivias G, et al.; ESC Committee for Practice Guidelines. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34:2281-2329. Go to original source... Go to PubMed...
  35. Burri H, Starck C, Auricchio A, et al. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). Europace 2021;23:983-1008. Go to original source... Go to PubMed...
  36. Belott P, Reynolds D. Permanent pacemaker and implantable cardioverter-defibrillator implantation in adults. In: Ellenbogen KA, Wilcoff BL, Kay NG, Lau CP, Auricchio A, eds. Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy. 5th ed. Elsevier; 2017. p. 631-691. Go to original source...
  37. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999;99:2993-3001. Go to original source... Go to PubMed...
  38. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-2395. Go to original source... Go to PubMed...
  39. Saxon LA, Bristow MR, Boehmer J, et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006;114:2766-2772. Go to original source... Go to PubMed...
  40. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. Go to original source... Go to PubMed...
  41. Moss AJ, Hall WJ, Cannom DS, et al.; MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338. Go to original source... Go to PubMed...
  42. Verma N, Knight BP. Update in cardiac pacing. Arrhythm Electrophysiol Rev 2019;8:228-233. Go to original source... Go to PubMed...
  43. Abdelrahman M, Subzposh FA, Beer D, et al. Clinical outcomes of His bundle pacing compared to right ventricular pacing. J Am Coll Cardiol 2018;71:2319-2330. Go to original source... Go to PubMed...
  44. Bhatt AG, Musat DL, Milstein N, et al. The efficacy of his bundle pacing: lessons learned from implementation for the first time at an experienced electrophysiology center. JACC Clin Electrophysiol 2018;4:1397-1406. Go to original source... Go to PubMed...
  45. Ali N, Keene D, Arnold A, et al. His bundle pacing: a new frontier in the treatment of heart failure. Arrhythm Electrophysiol Rev 2018;7:103-110. Go to original source... Go to PubMed...
  46. Reynolds D, Duray GZ, Omar R, et al.; Micra Transcatheter Pacing Study Group. A leadless intracardiac transcatheter pacing system. N Engl J Med 2016;374:533-541. Go to original source... Go to PubMed...
  47. Reddy VY, Exner DV, Cantillon DJ, et al.; Leadless II Study Investigators. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med 2015;373:1125-1135. Go to original source... Go to PubMed...
  48. Knops RE, Tjong FV, Neuzil P, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol 2015;65:1497-1504. Go to original source... Go to PubMed...
  49. Sperzel J, Defaye P, Delnoy PP, et al. Primary safety results from the LEADLESS Observational Study. Europace 2018;20:1491-1497. Go to original source... Go to PubMed...
  50. Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm 2017;14:1375-1379. Go to original source... Go to PubMed...
  51. El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real--world setting: a comparison to the investigational study and a transvenous historical control. Heart Rhythm 2018;15:1800-1807. Go to original source... Go to PubMed...
  52. Ovsyshcher I, Guetta V, Bondy C, Porath A. First derivative of right ventricular pressure, dP/dt, as a sensor for a rate adaptive VVI pacemaker: initial experience. Pacing Clin Electrophysiol 1992;15:211-218. Go to original source... Go to PubMed...
  53. Lau CP, Butrous GS, Ward DE, Camm AJ. Comparison of exercise performance of six rate-adaptive right ventricular cardiac pacemakers. Am J Cardiol 1989;63:833-838. Go to original source... Go to PubMed...
  54. Lau CP, Antoniou A, Ward DE, Camm AJ. Initial clinical experience with a minute ventilation sensing rate modulated pacemaker: improvements in exercise capacity and symptomatology. Pacing Clin Electrophysiol 1988;11:1815-1822. Go to original source... Go to PubMed...
  55. Benditt DG, Mianulli M, Fetter J, et al. Single‑chamber cardiac pacing with activity-initiated chronotropic response: evaluation by cardiopulmonary exercise testing. Circulation 1987;75:184-191. Go to original source... Go to PubMed...
  56. Landzberg JS, Franklin JO, Mahawar SK, et al. Benefits of physiologic atrioventricular synchronization for pacing with an exercise rate response. Am J Cardiol 1990;66:193-197. Go to original source... Go to PubMed...
  57. Iwase M, Hatano K, Saito F, et al. Evaluation by exercise Doppler echocardiography of maintenance of cardiac output during ventricular pacing with or without chronotropic response. Am J Cardiol 1989;63:934-938. Go to original source... Go to PubMed...
  58. Buckingham TA, Woodruff RC, Pennington DG, et al. Effect of ventricular function on the exercise hemodynamics of variable rate pacing. J Am Coll Cardiol 1988;11:1269-1277. Go to original source... Go to PubMed...
  59. Padeletti L, Pieragnoli P, Di Biase L, et al. Is a dual-sensor pacemaker appropriate in patients with sino-atrial disease? Results from the DUSISLOG study. Pacing Clin Electrophysiol 2006;29:34-40. Go to original source... Go to PubMed...
  60. Nowak B, Misselwitz B, Expert committee 'Pacemaker Institute of Quality Assurance Hessen', et al. Do gender differences exist in pacemaker implantation? - results of an obligatory external quality control program. Europace 2010;12:210-215. Go to original source... Go to PubMed...
  61. Mohamed MO, Volgman AS, Contractor T, et al. Trends of sex differences in outcomes of cardiac electronic device implantations in the United States. Can J Cardiol 2020;36:69-78. Go to original source... Go to PubMed...
  62. Moore K, Ganesan A, Labrosciano C, et al. Sex differences in acute complications of cardiac implantable electronic devices: implications for patient safety. J Am Heart Assoc 2019;8:e010869. Go to original source... Go to PubMed...
  63. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 2018;39:1883-1948. Go to original source... Go to PubMed...
  64. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015;36:2793-2867. Go to original source... Go to PubMed...
  65. Kaess BM, Andersson C, Duncan MS, et al. Familial clustering of cardiac conduction defects and pacemaker insertion. Circ Arrhythm Electrophysiol 2019;12:e007150. Go to original source... Go to PubMed...
  66. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Heart Rhythm 2011;8:1308-1339. Go to original source... Go to PubMed...
  67. Kerr SR, Pearce MS, Brayne C, et al. Carotid sinus hypersensitivity in asymptomatic older persons: implications for diagnosis of syncope and falls. Arch Intern Med 2006;166:515-520. Go to original source... Go to PubMed...
  68. Puggioni E, Guiducci V, Brignole M, et al. Results and complications of the carotid sinus massage performed according to the 'method of symptoms'. Am J Cardiol 2002;89:599-601. Go to original source... Go to PubMed...
  69. Brignole M, Ungar A, Casagranda I, et al. Prospective multicentre systematic guideline-based management of patients referred to the Syncope Units of general hospitals. Europace 2010;12:109-118. Go to original source... Go to PubMed...
  70. Solari D, Maggi R, Oddone D, et al. Clinical context and outcome of carotid sinus syndrome diagnosed by means of the 'method of symptoms'. Europace 2014;16:928-934. Go to original source... Go to PubMed...
  71. Solari D, Maggi R, Oddone D, et al. Assessment of the vasodepressor reflex in carotid sinus syndrome. Circ Arrhythm Electrophysiol 2014;7:505-510. Go to original source... Go to PubMed...
  72. Mangrum JM, DiMarco JP. The evaluation and management of bradycardia. N Engl J Med 2000;342:703-709. Go to original source... Go to PubMed...
  73. Sutton R. Reflex atrioventricular block. Front Cardiovasc Med 2020;7:4-8.73a. Da Costa D, Brady WJ, Edhouse J. Bradycardias and atrioventricular conduction block. BMJ 2002;324:535-538. Go to original source... Go to PubMed...
  74. Steinberg JS, Varma N, Cygankiewicz I, et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Heart Rhythm 2017;14:e55-e96. Go to original source... Go to PubMed...
  75. Brubaker PH, Kitzman DW. Chronotropic incompetence: causes, consequences, and management. Circulation 2011;123:1010-1020. Go to original source... Go to PubMed...
  76. Savonen KP, Kiviniemi V, Laukkanen JA, et al. Chronotropic incompetence and mortality in middle-aged men with known or suspected coronary heart disease. Eur Heart J 2008;29:1896-1902. Go to original source... Go to PubMed...
  77. Byrne JM, Marais HJ, Cheek GA. Exercise-induced complete heart block in a patient with chronic bifascicular block. J Electrocardiol 1994;27:339-342. Go to original source... Go to PubMed...
  78. Wissocq L, Ennezat PV, Mouquet F. Exercise-induced high-degree atrioventricular block. Arch Cardiovasc Dis 2009;102:733-735. Go to original source... Go to PubMed...
  79. Woelfel AK, Simpson RJ Jr, Gettes LS, Foster JR. Exercise--induced distal atrioventricular block. J Am Coll Cardiol 1983;2:578-581. Go to original source... Go to PubMed...
  80. Sumiyoshi M, Nakata Y, Yasuda M, et al. Clinical and electrophysiologic features of exercise-induced atrioventricular block. Am Heart J 1996;132:1277-1281. Go to original source... Go to PubMed...
  81. Oliveros RA, Seaworth J, Weiland FL, Boucher CA. Intermittent left anterior hemiblock during treadmill exercise test. Correlation with coronary arteriogram. Chest 1977;72:492-494. Go to original source... Go to PubMed...
  82. Bharati S, Dhingra RC, Lev M, et al. Conduction system in a patient with Prinzmetal's angina and transient atrioventricular block. Am J Cardiol 1977;39:120-125. Go to original source... Go to PubMed...
  83. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2019;41:407-477. Go to original source... Go to PubMed...
  84. Halliday BP, Gulati A, Ali A, et al. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation 2017;135:2106-2115. Go to original source... Go to PubMed...
  85. Kazmirczak F, Chen KA, Adabag S, et al. Assessment of the 2017 AHA/ACC/HRS Guideline recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis. Circ Arrhythm Electrophysiol 2019;12:e007488. Go to original source... Go to PubMed...
  86. Aquaro GD, Perfetti M, Camastra G, et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY Study. J Am Coll Cardiol 2017;70:1977-1987. Go to original source... Go to PubMed...
  87. Ferreira VM, Schulz-Menger J, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 2018;72:3158-3176. Go to original source... Go to PubMed...
  88. Zhou Y, Lower EE, Li HP, et al. Cardiac sarcoidosis: the impact of age and implanted devices on survival. Chest 2017;151:139-148. Go to original source... Go to PubMed...
  89. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011;4:303-309. Go to original source... Go to PubMed...
  90. Turner JJO. Hypercalcaemia - presentation and management. Clin Med (Lond) 2017;17:270-273. Go to original source... Go to PubMed...
  91. Chon SB, Kwak YH, Hwang SS, et al. Severe hyperkalemia can be detected immediately by quantitative electrocardiography and clinical history in patients with symptomatic or extreme bradycardia: a retrospective cross-sectional study. J Crit Care 2013;28:1112.e7-1112.e13. Go to original source... Go to PubMed...
  92. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-141. Go to original source... Go to PubMed...
  93. Wan D, Blakely C, Branscombe P, et al. Lyme carditis and high-degree atrioventricular block. Am J Cardiol 2018;121:1102-1104. Go to original source... Go to PubMed...
  94. Nakayama Y, Ohno M, Yonemura S, et al. A case of transient 2:1 atrioventricular block, resolved by thyroxine supplementation for subclinical hypothyroidism. Pacing Clin Electrophysiol 2006;29:106-108. Go to original source... Go to PubMed...
  95. Noble K, Isles C. Hyperkalaemia causing profound bradycardia. Heart 2006;92:10-63. Go to original source... Go to PubMed...
  96. Ishikawa T, Tsuji Y, Makita N. Inherited bradyarrhythmia: a diverse genetic background. J Arrhythm 2016;32:352-358. Go to original source... Go to PubMed...
  97. Smits JP, Veldkamp MW, Wilde AA. Mechanisms of inherited cardiac conduction disease. Europace 2005;7:122-137. Go to original source... Go to PubMed...
  98. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013;10:1932-1963. Go to original source... Go to PubMed...
  99. Brodsky M, Wu D, Denes P, et al. Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 1977;39:390-395. Go to original source... Go to PubMed...
  100. Clarke JM, Hamer J, Shelton JR, et al. The rhythm of the normal human heart. Lancet 1976;1:508-512. Go to original source... Go to PubMed...
  101. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982;81:302-307. Go to original source... Go to PubMed...
  102. Grimm W, Hoffmann J, Menz V, et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996;77:1310-1314. Go to original source... Go to PubMed...
  103. Zwillich C, Devlin T, White D, et al. Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest 1982;69:1286-1292. Go to original source... Go to PubMed...
  104. Guilleminault C, Pool P, Motta J, Gillis AM. Sinus arrest during REM sleep in young adults. N Engl J Med 1984;311:1006-1010. Go to original source... Go to PubMed...
  105. Grimm W, Koehler U, Fus E, e al. Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol 2000;86:688-692. Go to original source... Go to PubMed...
  106. Koehler U, Fus E, Grimm W, et al. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998;11:434-439. Go to original source... Go to PubMed...
  107. Simantirakis EN, Schiza SI, Marketou ME, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J 2004;25:1070-1076. Go to original source... Go to PubMed...
  108. Sutton R, Fedorowski A, Olshansky B, et al. Tilt testing remains a valuable asset. Eur Heart J 2021;42:1654-1660. Go to original source... Go to PubMed...
  109. Da Costa A, Defaye P, Romeyer-Bouchard C, et al. Clinical impact of the implantable loop recorder in patients with isolated syncope, bundle branch block and negative workup: a randomized multicentre prospective study. Arch Cardiovasc Dis 2013;106:146-154. Go to original source... Go to PubMed...
  110. Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J 2006;27:351-356. Go to original source... Go to PubMed...
  111. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46-51. Go to original source... Go to PubMed...
  112. Podoleanu C, DaCosta A, Defaye P, et al. Early use of an implantable loop recorder in syncope evaluation: a randomized study in the context of the French Healthcare system (FRESH study). Arch Cardiovasc Dis 2014;107:546-552. Go to original source... Go to PubMed...
  113. Sulke N, Sugihara C, Hong P, et al. The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial. Europace 2016;18:912-918. Go to original source... Go to PubMed...
  114. Gann D, Tolentino A, Samet P. Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study. Ann Intern Med 1979;90:24-29. Go to original source... Go to PubMed...
  115. Menozzi C, Brignole M, Alboni P, et al. The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome. Am J Cardiol 1998;82:1205-1209. Go to original source... Go to PubMed...
  116. McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of 'high-risk' bundle-branch block: final report of a prospective study. N Engl J Med 1982;307:137-143. Go to original source... Go to PubMed...
  117. Gronda M, Magnani A, Occhetta E, et al. Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications. G Ital Cardiol 1984;14:768-773. Go to PubMed...
  118. Bergfeldt L, Edvardsson N, Rosenqvist M, et al. Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia-detecting pacemaker. Am J Cardiol 1994;74:1129-1132. Go to original source... Go to PubMed...
  119. Kaul U, Dev V, Narula J, et l. Evaluation of patients with bundle branch block and 'unexplained' syncope: a study based on comprehensive electrophysiologic testing and ajmaline stress. Pacing Clin Electrophysiol 1988;11:289-297. Go to original source... Go to PubMed...
  120. Moya A, Garcia-Civera R, Croci F, et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J 2011;32:1535-1541. Go to original source... Go to PubMed...
  121. Twidale N, Heddle WF, Tonkin AM. Procainamide administration during electrophysiology study - utility as a provocative test for intermittent atrioventricular block. Pacing Clin Electrophysiol 1988;11:1388-1397.
  122. Scheinman MM, Peters RW, Suave MJ, et al. Value of the HQ interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982;50:1316-1322. Go to original source... Go to PubMed...
  123. Roca-Luque I, Oristrell G, Francisco-Pasqual J, et al. Predictors of positive electrophysiological study in patients with syncope and bundle branch block: PR interval and type of conduction disturbance. Clin Cardiol 2018;41:1537-1542. Go to original source... Go to PubMed...
  124. Brignole M, Menozzi C, Moya A, et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 2001;104:2045-2050. Go to original source... Go to PubMed...
  125. Rubenstein JJ, Schulman CL, Yurchak PM, DeSanctis RW. Clinical spectrum of the sick sinus syndrome. Circulation 1972;46:5-13. Go to original source... Go to PubMed...
  126. Short DS. The syndrome of alternating bradycardia and tachycardia. Br Heart J 1954;16:208-214. Go to original source... Go to PubMed...
  127. Goldberger JJ, Johnson NP, Gidea C. Significance of asymptomatic bradycardia for subsequent pacemaker implantation and mortality in patients >60 years of age. Am J Cardiol 2011;108:857-861. Go to original source... Go to PubMed...
  128. Nielsen JC, Thomsen PE, Hojberg S, et al.; DANPACE Investigators. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J 2011;32:686-696. Go to original source... Go to PubMed...
  129. Breivik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent pacemaker in 109 patients. A follow-up study. Acta Med Scand 1979;206:153-159. Go to original source... Go to PubMed...
  130. Hartel G, Talvensaari T. Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients. Acta Med Scand 1975;198:341-347. Go to original source... Go to PubMed...
  131. Rasmussen K. Chronic sinus node disease: natural course and indications for pacing. Eur Heart J 1981;2:455-459. Go to original source... Go to PubMed...
  132. Sasaki Y, Shimotori M, Akahane K, et al. Long-term follow--up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. Pacing Clin Electrophysiol 1988;11:1575-1583. Go to original source... Go to PubMed...
  133. Senturk T, Xu H, Puppala K, et al. Cardiac pauses in competitive athletes: a systematic review examining the basis of current practice recommendations. Europace 2016;18:1873-1879. Go to original source... Go to PubMed...
  134. Brignole M, Menozzi C, Moya A, et al.; International Study on Syncope of Uncertain Etiology Investigators. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 2012;125:2566-2571. Go to original source... Go to PubMed...
  135. Brignole M, Sutton R, Menozzi C, et al.; International Study on Syncope of Uncertain Etiology Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 2006;27:1085-1092. Go to original source... Go to PubMed...
  136. Asseman P, Berzin B, Desry D, et al. Persistent sinus nodal electrograms during abnormally prolonged postpacing atrial pauses in sick sinus syndrome in humans: sinoatrial block vs overdrive suppression. Circulation 1983;68:33-41. Go to original source... Go to PubMed...
  137. Calkins H, Hindricks G, Cappato R, et al.; Document Reviewers. 2017 HRS/EHRA/ECAS/ APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2018;20:e1-e160. Go to original source... Go to PubMed...
  138. Chen YW, Bai R, Lin T, et al. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol 2014;37:403-411. Go to original source... Go to PubMed...
  139. Inada K, Yamane T, Tokutake K, et al. The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow- -up. Europace 2014;16:208-213. Go to original source... Go to PubMed...
  140. Jackson LR, 2nd, Rathakrishnan B, Campbell K, Thomas KL, Piccini JP, Bahnson T, Stiber JA, Daubert JP. Sinus node dysfunction and atrial fibrillation: a reversible phenomenon? Pacing Clin Electrophysiol 2017;40:442-450. Go to original source... Go to PubMed...
  141. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000; 342:1385-1391. Go to original source... Go to PubMed...
  142. Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial‑based pacing compared with ventricular pacing: meta‑analysis of randomized trials, using individual patient data. Circulation 2006;114:11-17. Go to original source... Go to PubMed...
  143. Ross RA, Kenny RA. Pacemaker syndrome in older people. Age Ageing 2000;29:13-15. Go to original source... Go to PubMed...
  144. Mitsuoka T, Kenny RA, Yeung TA, et al. Benefits of dual chamber pacing in sick sinus syndrome. Br Heart J 1988;60:338-347. Go to original source... Go to PubMed...
  145. Sweeney MO, Bank AJ, Nsah E, et al.; Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007;357:1000-1008. Go to original source... Go to PubMed...
  146. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-1216. Go to original source... Go to PubMed...
  147. Andersen HR, Thuesen L, Bagger JP, et al. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344:1523-1528. Go to original source... Go to PubMed...
  148. Kristensen L, Nielsen JC, Mortensen PT, et al. Incidence of atrial fibrillation and thromboembolism in a randomized trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart 2004;90:661-666. Go to original source... Go to PubMed...
  149. Wilkoff BL, Cook JR, Epstein AE, et al.; Dual Chamber VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123. Go to original source... Go to PubMed...
  150. Cheng S, Keyes MJ, Larson MG, et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 2009;301:2571-2577. Go to original source... Go to PubMed...
  151. Nielsen JC, Thomsen PE, Hojberg S, et al.; DANPACE Investigators. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. Europace 2012;14:682-689. Go to original source... Go to PubMed...
  152. Auricchio A, Ellenbogen KA. Reducing ventricular pacing frequency in patients with atrioventricular block: is it time to change the current pacing paradigm? Circ Arrhythm Electrophysiol 2016;9:e004404. Go to original source... Go to PubMed...
  153. Shurrab M, Healey JS, Haj-Yahia S, et al. Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis. Europace 2017;19:282-288. Go to original source... Go to PubMed...
  154. Jankelson L, Bordachar P, Strik M, et al. Reducing right ventricular pacing burden: algorithms, benefits, and risks. Europace 2019;21:539-547. Go to original source... Go to PubMed...
  155. Pascale P, Pruvot E, Graf D. Pacemaker syndrome during managed ventricular pacing mode: what is the mechanism? J Cardiovasc Electrophysiol 2009;20:574-576. Go to original source... Go to PubMed...
  156. Mansour F, Khairy P. Electrical storm due to managed ventricular pacing. Heart Rhythm 2012;9:842-843. Go to original source... Go to PubMed...
  157. Sekita G, Hayashi H, Nakazato Y, Daida H. Ventricular fibrillation induced by short-long-short sequence during managed ventricular pacing. J Cardiovasc Electrophysiol 2011;22:1181. Go to original source... Go to PubMed...
  158. Vavasis C, Slotwiner DJ, Goldner BG, Cheung JW. Frequent recurrent polymorphic ventricular tachycardia during sleep due to managed ventricular pacing. Pacing Clin Electrophysiol 2010;33:641-644. Go to original source... Go to PubMed...
  159. van Mechelen R, Schoonderwoerd R. Risk of managed ventricular pacing in a patient with heart block. Heart Rhythm 2006;3:1384-1385. Go to original source... Go to PubMed...
  160. Stockburger M, Boveda S, Moreno J, et al. Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population. Eur Heart J 2015;36:151-157. Go to original source... Go to PubMed...
  161. Healey JS, Connolly SJ, Gold MR, et al.; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-129. Go to original source... Go to PubMed...
  162. Munawar DA, Mahajan R, Agbaedeng TA, et al. Implication of ventricular pacing burden and atrial pacing therapies on the progression of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm 2019;16:1204-1214. Go to original source... Go to PubMed...
  163. Padeletti L, Purerfellner H, Mont L, et al.; MINERVA Investigators. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia:results from the MINERVA randomized multicenter international trial. Heart Rhythm 2015;12:1717-1725. Go to original source... Go to PubMed...
  164. Pujol-Lopez M, San Antonio R, Tolosana JM, Mont L. Programming pacemakers to reduce and terminate atrial fibrillation. Curr Cardiol Rep 2019;21:127. Go to original source... Go to PubMed...
  165. Boriani G, Tukkie R, Manolis AS, et al.; MINERVA Investigators. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J 2014;35:2352-2362. Go to original source... Go to PubMed...
  166. Crossley GH, Padeletti L, Zweibel S, et al. Reactive atrial--based antitachycardia pacing therapy reduces atrial tachyarrhythmias. Pacing Clin Electrophysiol 2019;42:970-979. Go to original source... Go to PubMed...
  167. Stockburger M, Gomez-Doblas JJ, Lamas G, et al. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF). Eur J Heart Fail 2011;13:633-641. Go to original source... Go to PubMed...
  168. Stockburger M, Defaye P, Boveda S, et al. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity - a sub-study of the ANSWER trial. Europace 2016;18:739-746. Go to original source... Go to PubMed...
  169. Thibault B, Simpson C, Gagne CE, et al. Impact of AV conduction disorders on SafeR mode performance. Pacing Clin Electrophysiol 2009;32 Suppl 1:S231-235. Go to original source... Go to PubMed...
  170. Thibault B, Ducharme A, Baranchuk A, et al.; CAN-SAVE R Study Investigators. Very low ventricular pacing rates can be achieved safely in a heterogeneous pacemaker population and provide clinical benefits: the CANadian Multi-Centre Randomised Study-Spontaneous AtrioVEntricular Conduction pReservation (CAN-SAVE R) Trial. J Am Heart Assoc 2015;4:e001983. Go to original source... Go to PubMed...
  171. Bellocci F, Spampinato A, Ricci R, et al. Antiarrhythmic benefits of dual chamber stimulation with rate‑response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace 1999;1:220-225. Go to original source... Go to PubMed...
  172. Santini M, Ricci R, Puglisi A, et al. Long-term haemodynamic and antiarrhythmic benefits of DDIR versus DDI pacing mode in sick sinus syndrome and chronotropic incompetence. G Ital Cardiol 1997;27:892-900. Go to PubMed...
  173. Capucci A, Boriani G, Specchia S, et al. Evaluation by cardiopulmonary exercise test of DDDR versus DDD pacing. Pacing Clin Electrophysiol 1992;15:1908-1913. Go to original source... Go to PubMed...
  174. Lamas GA, Knight JD, Sweeney MO, et al. Impact of rate- -modulated pacing on quality of life and exercise capacity - evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). Heart Rhythm 2007;4:1125-1132. Go to original source... Go to PubMed...
  175. Hocini M, Sanders P, Deisenhofer I, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation 2003;108:1172-1175. Go to original source... Go to PubMed...
  176. Mymin D, Mathewson FA, Tate RB, Manfreda J. The natural history of primary first-degree atrioventricular heart block. N Engl J Med 1986;315:1183-1187. Go to original source... Go to PubMed...
  177. Barold SS, Ilercil A, Leonelli F, Herweg B. First-degree atrioventricular block. Clinical manifestations, indications for pacing, pacemaker management & consequences during cardiac resynchronization. J Interv Card Electrophysiol 2006;17:139-152. Go to original source... Go to PubMed...
  178. Shaw DB, Gowers JI, Kekwick CA, et al. Is Mobitz type I atrioventricular block benign in adults? Heart 2004;90:169-174. Go to original source... Go to PubMed...
  179. Coumbe AG, Naksuk N, Newell MC, et al. Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block. Heart 2013;99:334-338. Go to original source... Go to PubMed...
  180. Strasberg B, Amat YLF, Dhingra RC, et al. Natural history of chronic second-degree atrioventricular nodal block. Circulation 1981;63:10431049. Go to original source... Go to PubMed...
  181. Dhingra RC, Denes P, Wu D, et al. The significance of second degree atrioventricular block and bundle branch block. Observations regarding site and type of block. Circulation 1974;49:638-646. Go to original source... Go to PubMed...
  182. Toff WD, Camm AJ, Skehan JD, United Kingdom Pacing Cardiovascular Events Trial Investigators. Single‑chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005;353:145-155. Go to original source... Go to PubMed...
  183. Castelnuovo E, Stein K, Pitt M, Garside R, Payne E. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess 2005;9:iii,xi-xiii, 1-246. Go to original source... Go to PubMed...
  184. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-2937. Go to original source... Go to PubMed...
  185. Nahlawi M, Waligora M, Spies SM, et al. Left ventricular function during and after right ventricular pacing. J Am Coll Cardiol 2004;44:1883-1888. Go to original source... Go to PubMed...
  186. Sweeney MO, Prinzen FW. A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 2006;47:282-288. Go to original source... Go to PubMed...
  187. Tayal B, Fruelund P, Sogaard P, et al. Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry- -based follow-up study. Eur Heart J 2019;40:3641-3648. Go to original source... Go to PubMed...
  188. Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm 2014;11:1619-1625. Go to original source... Go to PubMed...
  189. Kiehl EL, Makki T, Kumar R, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm 2016;13:2272-2278. Go to original source... Go to PubMed...
  190. Khurshid S, Obeng-Gyimah E, Supple GE, et al. Reversal of pacing-induced cardiomyopathy following cardiac resynchronization therapy. JACC Clin Electrophysiol 2018;4:168-177. Go to original source... Go to PubMed...
  191. Curtis AB, Worley SJ, Adamson PB, et al.; Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 2013;368:1585-1593. Go to original source... Go to PubMed...
  192. Pitcher D, Papouchado M, James MA, Rees JR. Twenty four hour ambulatory electrocardiography in patients with chronic atrial fibrillation. Br Med J (Clin Res Ed) 1986;292:594. Go to original source... Go to PubMed...
  193. Chatterjee NA, Upadhyay GA, Ellenbogen KA, et al. Atrioventricular nodal ablation in atrial fibrillation: a meta- -analysis and systematic review. Circ Arrhythm Electrophysiol 2012;5:68-76. Go to original source... Go to PubMed...
  194. Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001;344:1043-1051. Go to original source... Go to PubMed...
  195. Garcia B, Clementy N, Benhenda N, et al. Mortality after atrioventricular nodal radiofrequency catheter ablation with permanent ventricular pacing in atrial fibrillation: outcomes from a controlled nonrandomized study. Circ Arrhythm Electrophysiol 2016;9:e003993. Go to original source... Go to PubMed...
  196. Brignole M, Pokushalov E, Pentimalli F, et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. Eur Heart J 2018;39:3999-4008. Go to original source... Go to PubMed...
  197. Doshi RN, Daoud EG, Fellows C, et al.; PAVE Study Group. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-1165. Go to original source... Go to PubMed...
  198. Huang W, Su L, Wu S, et al. Benefits of permanent His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction. J Am Heart Assoc 2017;6:e005309. Go to original source... Go to PubMed...
  199. Vijayaraman P, Subzposh FA, Naperkowski A. Atrioventricular node ablation and His bundle pacing. Europace 2017;19:iv10-iv16. Go to original source... Go to PubMed...
  200. Deshmukh P, Casavant DA, Romanyshyn M, Anderson K. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His Purkinje activation. Circulation 2000;101:869-877. Go to original source... Go to PubMed...
  201. Occhetta E, Bortnik M, Magnani A, et al. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol 2006;47:1938-1945. Go to original source... Go to PubMed...
  202. Lau CP, Rushby J, Leigh-Jones M, et al. Symptomatology and quality of life in patients with rate-responsive pacemakers: a double-blind, randomized, crossover study. Clin Cardiol 1989;12:505-512. Go to original source... Go to PubMed...
  203. Leung SK, Lau CP. Developments in sensor-driven pacing. Cardiol Clin 2000;18:113-155, ix. Go to original source... Go to PubMed...
  204. Oto MA, Muderrisoglu H, Ozin MB, et al. Quality of life in patients with rate responsive pacemakers: a randomized, cross-over study. Pacing Clin Electrophysiol 1991;14:800-806. Go to original source... Go to PubMed...
  205. Proietti R, Manzoni G, Di Biase L, et al. Closed loop stimulation is effective in improving heart rate and blood pressure response to mental stress: report of a single-chamber pacemaker study in patients with chronotropic incompetent atrial fibrillation. Pacing Clin Electrophysiol 2012;35:990-998. Go to original source... Go to PubMed...
  206. Barold SS. Indications for permanent cardiac pacing in first-degree AV block: class I, II, or III? Pacing Clin Electrophysiol 1996;19:747-751. Go to original source... Go to PubMed...
  207. Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual- -chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992;340:1308-1312. Go to original source... Go to PubMed...
  208. Carroz P, Delay D, Girod G. Pseudo-pacemaker syndrome in a young woman with first-degree atrio-ventricular block. Europace 2010;12:594-596. Go to original source... Go to PubMed...
  209. Englund A, Bergfeldt L, Rehnqvist N, et al. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope. J Am Coll Cardiol 1995;26:1508-1515. Go to original source... Go to PubMed...
  210. Morady F, Higgins J, Peters RW, et al. Electrophysiologic testing in bundle branch block and unexplained syncope. Am J Cardiol 1984;54:587-591. Go to original source... Go to PubMed...
  211. Tabrizi F, Rosenqvist M, Bergfeldt L, Englund A. Long-term prognosis in patients with bifascicular block - the predictive value of noninvasive and invasive assessment. J Intern Med 2006;260:31-38. Go to original source... Go to PubMed...
  212. Olshansky B, Hahn EA, Hartz VL, et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. Am Heart J 1999;137:878-886. Go to original source... Go to PubMed...
  213. Roca-Luque I, Francisco-Pasqual J, Oristrell G, et al. Flecainide versus procainamide in electrophysiological study in patients with syncope and wide QRS duration. JACC Clin Electrophysiol 2019;5:212-219. Go to original source... Go to PubMed...
  214. Santini M, Castro A, Giada F, et al. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study. Circ Arrhythm Electrophysiol 2013;6:101-107. Go to original source... Go to PubMed...
  215. Camm AJ, Lüscher TF, Maurer G, Serruys PW (eds). ESC CardioMed. 3rd ed. Oxford, UK: Oxford University Press; 2018. Go to original source...
  216. Peters RW, Scheinman MM, Modin C, et al. Prophylactic permanent pacemakers for patients with chronic bundle branch block. Am J Med 1979;66:978-985. Go to original source... Go to PubMed...
  217. Armaganijan LV, Toff WD, Nielsen JC, et al. Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol 2012;35:131-134. Go to original source... Go to PubMed...
  218. Gadler F, Valzania C, Linde C. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. Europace 2015;17:69-77. Go to original source... Go to PubMed...
  219. Shurrab M, Elitzur Y, Healey JS, et al. VDD vs DDD pacemakers: a meta-analysis. Can J Cardiol 2014;30:1385-1391. Go to original source... Go to PubMed...
  220. Brignole M, Ammirati F, Arabia F, et al.; Syncope Unit Project Two Investigators. Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes. Eur Heart J 2015;36:1529-1535. Go to original source... Go to PubMed...
  221. Brignole M, Arabia F, Ammirati F, et al.; Syncope Unit Project investigators. Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study. Europace 2016;18:1427-1433. Go to original source... Go to PubMed...
  222. Sutton R, Brignole M. Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis. Eur Heart J 2014;35:2211-2212. Go to original source... Go to PubMed...
  223. Claesson JE, Kristensson BE, Edvardsson N, Wahrborg P. Less syncope and milder symptoms in patients treated with pacing for induced cardioinhibitory carotid sinus syndrome: a randomized study. Europace 2007;9:932-936. Go to original source... Go to PubMed...
  224. Brignole M, Menozzi C, Lolli G, et al. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol 1992;69:1039-1043. Go to original source... Go to PubMed...
  225. Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000;102:294-299. Go to original source... Go to PubMed...
  226. Ammirati F, Colivicchi F, Santini M, Syncope D, Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 2001;104:52-57. Go to original source... Go to PubMed...
  227. Baron-Esquivias G, Morillo CA, Moya-Mitjans A, et al. Dual--chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the SPAIN study. J Am Coll Cardiol 2017;70:1720-1728. Go to original source... Go to PubMed...
  228. Russo V, Rago A, Papa AA, et al. The effect of dual-chamber closed‑loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. Heart 2013;99:1609-1613. Go to original source... Go to PubMed...
  229. Brignole M, Russo V, Arabia F, et al.; BioSync CSL trial Investigators. Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole. Eur Heart J 2020;42:508-516. Go to original source... Go to PubMed...
  230. Russo V, Rago A, De Rosa M, et al. Does cardiac pacing reduce syncopal recurrences in cardioinhibitory vasovagal syncope patients selected with head-up tilt test? Analysis of a 5-year follow-up database. Int J Cardiol 2018;270:149-153. Go to original source... Go to PubMed...
  231. Flammang D, Church TR, De Roy L, et al.; ATP Multicenter Study. Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing. Circulation 2012;125:31-36. Go to original source... Go to PubMed...
  232. Connolly SJ, Sheldon R, Thorpe KE, et al.; VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 2003;289:2224-2229. Go to original source... Go to PubMed...
  233. Raviele A, Giada F, Menozzi C, et al.; Vasovagal Syncope Pacing Trial Investigators. A randomized, double‑blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 2004;25:1741-1748. Go to original source... Go to PubMed...
  234. Palmisano P, Dell'Era G, Russo V, et al. Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study. Europace 2018;20:859-866. Go to original source... Go to PubMed...
  235. Proclemer A, Facchin D, Feruglio GA. [Syncope of unknown origin after electrophysiologic study: is the treatment with pacemaker useful?]. G Ital Cardiol 1990;20:195-201. Go to PubMed...
  236. Raviele A, Proclemer A, Gasparini G, et al. Long-term follow--up of patients with unexplained syncope and negative electrophysiologic study. Eur Heart J 1989;10:127-132. Go to original source... Go to PubMed...
  237. Parry SW, Steen N, Bexton RS, et al. Pacing in elderly recurrent fallers with carotid sinus hypersensitivity: a randomised, double-blind, placebo controlled crossover trial. Heart 2009;95:405-409. Go to original source... Go to PubMed...
  238. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-1146. Go to original source... Go to PubMed...
  239. Dunlay SM, Weston SA, Jacobsen SJ, Roger VL. Risk factors for heart failure: a population-based case-control study. Am J Med 2009;122:1023-1028. Go to original source... Go to PubMed...
  240. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-313. Go to original source... Go to PubMed...
  241. Rawshani A, Rawshani A, Franzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2018;379:633-644. Go to original source... Go to PubMed...
  242. Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population‑based study of 4 million individuals. Lancet 2018;391:572-580. Go to original source... Go to PubMed...
  243. McDonagh TA, Metra M, Adamo M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-3726. Go to original source... Go to PubMed...
  244. Crespo-Leiro MG, Anker SD, Maggioni AP, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC--HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2016;18:613-625. Go to original source... Go to PubMed...
  245. Olshansky B, Day JD, Sullivan RM, et al. Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial. Heart Rhythm 2012;9:34-39. Go to original source... Go to PubMed...
  246. Gervais R, Leclercq C, Shankar A, et al.; CARE-HF investigators. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail 2009;11:699-705. Go to original source... Go to PubMed...
  247. Friedman DJ, Bao H, Spatz ES, et al. Association Between a Prolonged PR interval and outcomes of cardiac resynchronization therapy: a report from the National Cardiovascular Data Registry. Circulation 2016;134:1617-1628. Go to original source... Go to PubMed...
  248. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002;39:194-201. Go to original source... Go to PubMed...
  249. Leclercq C, Hare JM. Ventricular resynchronization: current state of the art. Circulation 2004;109:296-299. Go to original source... Go to PubMed...
  250. Patel N, Viles-Gonzalez J, Agnihotri K, et al. Frequency of in- -hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States. J Cardiovasc Electrophysiol 2018;29:1425-1435. Go to original source... Go to PubMed...
  251. Khan NK, Goode KM, Cleland JG, et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail 2007;9:491-501. Go to original source... Go to PubMed...
  252. Cleland JG, McDonagh T, Rigby AS, et al. The national heart failure audit for England and Wales 20082009. Heart 2011;97:876-886. Go to original source... Go to PubMed...
  253. Lund LH, Braunschweig F, Benson L, et al. Association between demographic, organizational, clinical, and socio--economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry. Eur J Heart Fail 2017;19:1270-1279. Go to original source... Go to PubMed...
  254. Dickstein K, Normand C, Auricchio A, et al. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients - who is doing what to whom and how? Eur J Heart Fail 2018;20:1039-1051. Go to original source... Go to PubMed...
  255. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033. Go to original source... Go to PubMed...
  256. Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109-2116. Go to original source... Go to PubMed...
  257. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880. Go to original source... Go to PubMed...
  258. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-118. Go to original source... Go to PubMed...
  259. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853. Go to original source... Go to PubMed...
  260. Abraham WT, Young JB, Leon AR, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-2868. Go to original source... Go to PubMed...
  261. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150. Go to original source... Go to PubMed...
  262. Cleland JG, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization‑Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27:1928-1932. Go to original source... Go to PubMed...
  263. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-1843. Go to original source... Go to PubMed...
  264. Daubert C, Gold MR, Abraham WT, et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 2009;54:1837-1846. Go to original source... Go to PubMed...
  265. Ruschitzka F, Abraham WT, Singh JP, et al. Cardiac resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med 2013;369:1395-1405. Go to original source... Go to PubMed...
  266. Goldenberg I, Kutyifa V, Moss AJ. Survival with cardiac- -resynchronization therapy. N Engl J Med 2014;371:477-478. Go to original source...
  267. Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 2013;34:3547-3556. Go to original source... Go to PubMed...
  268. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-1787. Go to original source... Go to PubMed...
  269. Funck RC, Mueller HH, Lunati M, et al. Characteristics of a large sample of candidates for permanent ventricular pacing included in the Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization Study (BioPace). Europace 2014;16:354-362. Go to original source... Go to PubMed...
  270. Sipahi I, Carrigan TP, Rowland DY, et al. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 2011;171:1454-1462. Go to original source... Go to PubMed...
  271. Sipahi I, Chou JC, Hyden M, et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J 2012;163:260-267.e263. Go to original source... Go to PubMed...
  272. Cunnington C, Kwok CS, Satchithananda DK, et al. Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalization in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials. Heart 2015;101:1456-1462. Go to original source... Go to PubMed...
  273. Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;123:1061-1072. Go to original source... Go to PubMed...
  274. Birnie DH, Ha A, Higginson L, et al. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail 2013;6:1190-1198. Go to original source... Go to PubMed...
  275. Bilchick KC, Kamath S, DiMarco JP, Stukenborg GJ. Bundle- -branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients. Circulation 2010;122:2022-2030. Go to original source... Go to PubMed...
  276. Woods B, Hawkins N, Mealing S, et al. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart 2015;101:1800-1806. Go to original source... Go to PubMed...
  277. Gold MR, Thebault C, Linde C, et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation 2012;126:822-829. Go to original source... Go to PubMed...
  278. Fantoni C, Kawabata M, Massaro R, et al. Right and left ventricular activation sequence in patients with heart failure and right bundle branch block: a detailed analysis using three-dimensional non-fluoroscopic electroanatomic mapping system. J Cardiovasc Electrophysiol 2005;16:112-119; discussion 120-121. Go to original source... Go to PubMed...
  279. Nery PB, Ha AC, Keren A, Birnie DH. Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: a systematic review. Heart Rhythm 2011;8:1083-1087. Go to original source... Go to PubMed...
  280. Kutyifa V, Stockburger M, Daubert JP, et al. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy. Circ Arrhythm Electrophysiol 2014;7:645-651. Go to original source... Go to PubMed...
  281. Kewcharoen J, Kanitsoraphan C. Prolonged PR interval and outcome in cardiac resynchronization therapy. Arq Bras Cardiol 2019;113:109-110. Go to original source... Go to PubMed...
  282. Steffel J, Robertson M, Singh JP, et al. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. Eur Heart J 2015;36:1983-1989. Go to original source... Go to PubMed...
  283. Arshad A, Moss AJ, Foster E, et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol 2011;57:813-820. Go to original source... Go to PubMed...
  284. Zusterzeel R, Selzman KA, Sanders WE, et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. JAMA Intern Med 2014;174:1340-1348. Go to original source... Go to PubMed...
  285. Zweerink A, Friedman DJ, Klem I, et al. Size Matters: Normalization of QRS duration to left ventricular dimension improves prediction of long-term cardiac resynchronization therapy outcome. Circ Arrhythm Electrophysiol 2018;11:e006767. Go to original source... Go to PubMed...
  286. Strauss DG, Selvester RH, Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol 2011;107:927-934. Go to original source... Go to PubMed...
  287. Lee AWC, O'Regan DP, Gould J, et al. Sex-dependent QRS guidelines for cardiac resynchronization therapy using computer model predictions. Biophys J 2019;117:2375-2381. Go to original source... Go to PubMed...
  288. Caputo ML, van Stipdonk A, Illner A, et al. The definition of left bundle branch block influences the response to cardiac resynchronization therapy. Int J Cardiol 2018;269:165-169. Go to original source... Go to PubMed...
  289. van Stipdonk AMW, Vanbelle S, Ter Horst IAH, et al. Large variability in clinical judgement and definitions of left bundle branch block to identify candidates for cardiac resynchronisation therapy. Int J Cardiol 2019;286:61-65. Go to original source... Go to PubMed...
  290. Tomlinson DR, Bashir Y, Betts TR, Rajappan K. Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 2009;11:638-642. Go to original source... Go to PubMed...
  291. Vancura V, Wichterle D, Ulc I, et al. The variability of automated QRS duration measurement. Europace 2017;19:636-643. Go to PubMed...
  292. Sze E, Samad Z, Dunning A, et al. Impaired recovery of left ventricular function in patients with cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2018;71:306-317. Go to original source... Go to PubMed...
  293. Swedberg K, Komajda M, Bohm M, et al.; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010;376:875-885. Go to original source...
  294. McMurray JJ, Packer M, Desai AS, et al.; PARADIGM-HF Investigators Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993-1004. Go to original source... Go to PubMed...
  295. Nijst P, Martens P, Dauw J, et al. Withdrawal of neurohumoral blockade after cardiac resynchronization therapy. J Am Coll Cardiol 2020;75:1426-1438. Go to original source... Go to PubMed...
  296. Mullens W, Auricchio A, Martens P, et al. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: a joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology. Eur J Heart Fail 2020;22:2349-2369. Go to original source... Go to PubMed...
  297. Hindricks G, Potpara T, Dagres N, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020;42:373-498. Go to original source... Go to PubMed...
  298. Ousdigian KT, Borek PP, Koehler JL, et al. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol 2014;7:370-376. Go to original source... Go to PubMed...
  299. Koplan BA, Kaplan AJ, Weiner S, et al. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 2009;53:355-360. Go to original source... Go to PubMed...
  300. Hayes DL, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011;8:1469-1475. Go to original source... Go to PubMed...
  301. Healey JS, Hohnloser SH, Exner DV, et al. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail 2012;5:566-570. Go to original source... Go to PubMed...
  302. Ganesan AN, Brooks AG, Roberts-Thomson KC, et al. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 2012;59:719-726. Go to original source... Go to PubMed...
  303. Gasparini M, Leclercq C, Lunati M, et al. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Heart Fail 2013;1:500-507. Go to original source... Go to PubMed...
  304. Kotecha D, Holmes J, Krum H, et al.; Beta-Blockers in Heart Failure Collaborative Group. Efficacy of beta blockers in -patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 2014;384:2235-2243. Go to original source... Go to PubMed...
  305. Ziff OJ, Samra M, Howard JP, et al. Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment. BMC Med 2020;18:103. Go to original source... Go to PubMed...
  306. Docherty KF, Shen L, Castagno D, et al. Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. Eur J Heart Fail 2020;22:528-538. Go to original source... Go to PubMed...
  307. Yin J, Hu H, Wang Y, et al. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta- -analysis. Clin Cardiol 2014;37:707-715. Go to original source... Go to PubMed...
  308. Tolosana JM, Arnau AM, Madrid AH, et al. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response? Eur J Heart Fail 2012;14:635-641. Go to original source... Go to PubMed...
  309. Tolosana JM, Trucco E, Khatib M, et al. Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy. Eur J Heart Fail 2013;15:1412-1418. Go to original source... Go to PubMed...
  310. Kamath GS, Cotiga D, Koneru JN, et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of non-responders after cardiac resynchronization therapy. J Am Coll Cardiol 2009;53:1050-1055. Go to original source... Go to PubMed...
  311. Hernandez-Madrid A, Facchin D, Klepfer RN, et al. Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for Efficacy analysis of CRT (OLE CRT) study. Heart Rhythm 2017;14:541-547. Go to original source... Go to PubMed...
  312. Plummer CJ, Frank CM, Bari Z, et al. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial. Heart Rhythm 2018;15:369-375. Go to original source... Go to PubMed...
  313. Tops LF, Schalij MJ, Holman ER, et al. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006;48:1642-1648. Go to original source... Go to PubMed...
  314. Brignole M, Botto G, Mont L, et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J 2011;32:2420-2429. Go to original source... Go to PubMed...
  315. Brignole M, Botto GL, Mont L, et al. Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation. Heart 2012;98:297-302. Go to original source... Go to PubMed...
  316. Stavrakis S, Garabelli P, Reynolds DW. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace 2012;14:1490-1497. Go to original source... Go to PubMed...
  317. Sharma PS, Vijayaraman P, Ellenbogen KA. Permanent His bundle pacing: shaping the future of physiological ventricular pacing. Nat Rev Cardiol 2020;17:22-36. Go to original source... Go to PubMed...
  318. Huang W, Su L, Wu S, et al. A Novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Can J Cardiol 2017;33:1736.e1-1736.e73. Go to original source... Go to PubMed...
  319. Sharma PS, Dandamudi G, Herweg B, et al. Permanent His--bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: a multicenter experience. Heart Rhythm 2018;15:413-420. Go to original source... Go to PubMed...
  320. Vijayaraman P, Herweg B, Ellenbogen KA, Gajek J. His- -optimized cardiac resynchronization therapy to maximize electrical resynchronization: a feasibility study. Circ Arrhythm Electrophysiol 2019;12:e006934. Go to original source... Go to PubMed...
  321. Boczar K, Sławuta A, Ząbek A, et al. Cardiac resynchronization therapy with His bundle pacing. Pacing Clin Electrophysiol 2019;42:374-380. Go to original source... Go to PubMed...
  322. Coluccia G, Vitale E, Corallo S, et al. Additional benefits of nonconventional modalities of cardiac resynchronization therapy using His bundle pacing. J Cardiovasc Electrophysiol 2020;31:647-657. Go to original source... Go to PubMed...
  323. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-2962. Go to original source... Go to PubMed...
  324. Yu CM, Chan JY, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009;361:2123-2134. Go to original source... Go to PubMed...
  325. Tanaka H, Hara H, Adelstein EC, et al. Comparative mechanical activation mapping of RV pacing to LBBB by 2D and 3D speckle tracking and association with response to resynchronization therapy. JACC Cardiovasc Imaging 2010;3:461-471. Go to original source... Go to PubMed...
  326. Marai I, Gurevitz O, Carasso S, et al. Improvement of congestive heart failure by upgrading of conventional to resynchronization pacemakers. Pacing Clin Electrophysiol 2006;29:880-884. Go to original source... Go to PubMed...
  327. Witte KK, Pipes RR, Nanthakumar K, Parker JD. Biventricular pacemaker upgrade in previously paced heart failure patients-improvements in ventricular dyssynchrony. J Card Fail 2006;12:199-204. Go to original source... Go to PubMed...
  328. Duray GZ, Israel CW, Pajitnev D, Hohnloser SH. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate. Europace 2008;10:48-52. Go to original source... Go to PubMed...
  329. Nagele H, Dodeck J, Behrens S, et al. Hemodynamics and prognosis after primary cardiac resynchronization system implantation compared to 'upgrade' procedures. Pacing Clin Electrophysiol 2008;31:1265-1271. Go to original source... Go to PubMed...
  330. Foley PW, Muhyaldeen SA, Chalil S, et al. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Europace 2009;11:495-501. Go to original source... Go to PubMed...
  331. Wokhlu A, Rea RF, Asirvatham SJ, et al. Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival. Heart Rhythm 2009;6:1439-1447. Go to original source... Go to PubMed...
  332. Fröhlich G, Steffel J, Hürlimann D, et al. Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. Eur Heart J 2010;31:1477-1485. Go to original source... Go to PubMed...
  333. Paparella G, Sciarra L, Capulzini L, et al. Long-term effects of upgrading to biventricular pacing: differences with cardiac resynchronization therapy as primary indication. Pacing Clin Electrophysiol 2010;33:841-849. Go to original source... Go to PubMed...
  334. Bogale N, Witte K, Priori S, et al. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Eur J Heart Fail 2011;13:974-983. Go to original source... Go to PubMed...
  335. Gage RM, Burns KV, Bank AJ. Echocardiographic and clinical response to cardiac resynchronization therapy in heart failure patients with and without previous right ventricular pacing. Eur J Heart Fail 2014;16:1199-1205. Go to original source... Go to PubMed...
  336. Tayal B, Gorcsan J 3rd, Delgado-Montero A, et al. Comparative long-term outcomes after cardiac resynchronization therapy in right ventricular paced patients versus native wide left bundle branch block patients. Heart Rhythm 2016;13:511-518. Go to original source... Go to PubMed...
  337. Ter Horst IA, Kuijpers Y, van't Sant J, et al. 'Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?' A single centre experience. Neth Heart J 2016;24:75-81. Go to original source... Go to PubMed...
  338. Lipar L, Srivathsan K, Scott LR. Short-term outcome of cardiac resynchronization therapy - a comparison between newly implanted and chronically right ventricle-paced patients. Int J Cardiol 2016;219:195-199. Go to original source... Go to PubMed...
  339. Vamos M, Erath JW, Bari Z, et al. Effects of upgrade versus de novo cardiac resynchronization therapy on clinical response and long-term survival: results from a multicenter study. Circ Arrhythm Electrophysiol 2017;10:e004471. Go to original source... Go to PubMed...
  340. Cheung JW, Ip JE, Markowitz SM, et al. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: a comparative analysis using a United States National Database 20032013. Heart Rhythm 2017;14:1043-1050. Go to original source... Go to PubMed...
  341. Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258-1263. Go to original source... Go to PubMed...
  342. Baker CM, Christopher TJ, Smith PF, et al. Addition of a left ventricular lead to conventional pacing systems in patients with congestive heart failure: feasibility, safety, and early results in 60 consecutive patients. Pacing Clin Electrophysiol 2002;25:1166-1171. Go to original source... Go to PubMed...
  343. Valls-Bertault V, Fatemi M, Gilard M, et al. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace 2004;6:438-443. Go to original source... Go to PubMed...
  344. Eldadah ZA, Rosen B, Hay I, et al. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging. Heart Rhythm 2006;3:435-442. Go to original source... Go to PubMed...
  345. Shimano M, Tsuji Y, Yoshida Y, et al. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block. Europace 2007;9:869-874. Go to original source... Go to PubMed...
  346. Laurenzi F, Achilli A, Avella A, et al. Biventricular upgrading in patients with conventional pacing system and congestive heart failure: results and response predictors. Pacing Clin Electrophysiol 2007;30:1096-1104. Go to original source... Go to PubMed...
  347. Vatankulu MA, Goktekin O, Kaya MG, et al. Effect of long- -term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices. Am J Cardiol 2009;103:1280-1284. Go to original source... Go to PubMed...
  348. Hoijer CJ, Meurling C, Brandt J. Upgrade to biventricular pacing in patients with conventional pacemakers and heart failure: a double-blind, randomized crossover study. Europace 2006;8:51-55. Go to original source... Go to PubMed...
  349. Delnoy PP, Ottervanger JP, Vos DH, et al. Upgrading to biventricular pacing guided by pressure-volume loop analysis during implantation. J Cardiovasc Electrophysiol 2011;22:677-683. Go to original source... Go to PubMed...
  350. van Geldorp IE, Vernooy K, Delhaas T, et al. Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace 2010;12:223-229. Go to original source... Go to PubMed...
  351. Leclercq C, Cazeau S, Lellouche D, et al. Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: the RD-CHF Study. Pacing Clin Electrophysiol 2007;30(Suppl 1):S23-S30. Go to original source... Go to PubMed...
  352. Kosztin A, Vamos M, Aradi D, et al. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis. Heart Fail Rev 2018;23:15-26. Go to original source... Go to PubMed...
  353. Linde CM, Normand C, Bogale N, et al. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II. Eur J Heart Fail 2018;20:1457-1468. Go to original source... Go to PubMed...
  354. Raatikainen MJP, Arnar DO, Merkely B, et al. A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 report from the European Heart Rhythm Association. Europace 2017;19:ii1-ii90. Go to original source... Go to PubMed...
  355. Kirkfeldt RE, Johansen JB, Nohr EA, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 2014;35:1186-1194. Go to original source... Go to PubMed...
  356. Boriani G, Diemberger I. Cardiac resynchronization therapy in the real world: need to upgrade outcome research. Eur J Heart Fail 2018;20:1469-1471. Go to original source... Go to PubMed...
  357. Merkely B, Kosztin A, Roka A, et al. Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial. Europace 2017;19:1549-1555. Go to original source... Go to PubMed...
  358. Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927-1937. Go to original source... Go to PubMed...
  359. Martinelli Filho M, de Siqueira SF, Costa R, et al. Conventional versus biventricular pacing in heart failure and bradyarrhythmia: the COMBAT study. J Card Fail 2010;16:293-300. Go to original source... Go to PubMed...
  360. Yu CM, Fang F, Luo XX, et al. Long-term follow-up results of the pacing to avoid cardiac enlargement (PACE) trial. Eur J Heart Fail 2014;16:1016-1025. Go to original source... Go to PubMed...
  361. Albertsen AE, Mortensen PT, Jensen HK, et al. Adverse effect of right ventricular pacing prevented by biventricular pacing during long-term follow-up: a randomized comparison. Eur J Echocardiogr 2011;12:767-772. Go to original source... Go to PubMed...
  362. Chung ES, St John Sutton MG, Mealing S, et al. Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study. J Med Econ 2019;22:1088-1095. Go to original source... Go to PubMed...
  363. Orlov MV, Gardin JM, Slawsky M, et al. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J 2010;159:264-270. Go to original source... Go to PubMed...
  364. Carson P, Anand I, O'Connor C, et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005;46:2329-2334. Go to original source... Go to PubMed...
  365. Barsheshet A, Wang PJ, Moss AJ, et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011;57:2416-2423. Go to original source... Go to PubMed...
  366. Gold MR, Linde C, Abraham WT, et al. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm 2011;8:679-684. Go to original source... Go to PubMed...
  367. Sapp JL, Parkash R, Wells GA, et al. Cardiac resynchronization therapy reduces ventricular arrhythmias in primary but not secondary prophylactic implantable cardioverter defibrillator patients: insight from the Resynchronization in Ambulatory Heart Failure trial. Circ Arrhythm Electrophysiol 2017;10:e004875. Go to original source... Go to PubMed...
  368. Kutyifa V, Moss AJ, Solomon SD, et al. Reduced risk of life-threatening ventricular tachyarrhythmias with cardiac resynchronization therapy: relationship to left ventricular ejection fraction. Eur J Heart Fail 2015;17:971-978. Go to original source... Go to PubMed...
  369. Gold MR, Daubert JC, Abraham WT, et al. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE). Circ Arrhythm Electrophysiol 2013;6:1163-1168. Go to original source... Go to PubMed...
  370. Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med 2011;154:401-412. Go to original source... Go to PubMed...
  371. Lam SK, Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials. BMJ 2007;335:925. Go to original source... Go to PubMed...
  372. Kutyifa V, Geller L, Bogyi P, et al. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. Eur J Heart Fail 2014;16:1323-1330. Go to original source... Go to PubMed...
  373. Barra S, Boveda S, Providencia R, et al. Adding defibrillation therapy to cardiac resynchronization on the basis of the myocardial substrate. J Am Coll Cardiol 2017;69:1669-1678. Go to original source... Go to PubMed...
  374. Leyva F, Zegard A, Umar F, et al. Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy. Europace 2018;20:1804-1812. Go to original source... Go to PubMed...
  375. Kober L, Thune JJ, Nielsen JC, et al.; DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016;375:1221-1230. Go to original source... Go to PubMed...
  376. Leyva F, Zegard A, Okafor O, et al. Survival after cardiac resynchronization therapy: results from 50 084 implantations. Europace 2019;21:754-762. Go to original source... Go to PubMed...
  377. Gras M, Bisson A, Bodin A, et al. Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention. Europace 2020;22:1224-1233. Go to original source... Go to PubMed...
  378. Marijon E, Leclercq C, Narayanan K, et al. Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study. Eur Heart J 2015;36:2767-2776. Go to original source... Go to PubMed...
  379. Morani G, Gasparini M, Zanon F, et al. Cardiac resynchronization therapy‑defibrillator improves long-term survival compared with cardiac resynchronization therapy- -pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry. Europace 2013;15:1273-1279. Go to original source... Go to PubMed...
  380. Acosta J, Fernandez-Armenta J, Borras R, et al. Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patients with cardiac resynchronization therapy: the GAUDI-CRT study. JACC Cardiovasc Imaging 2018;11:561-572. Go to original source... Go to PubMed...
  381. Leyva F, Zegard A, Acquaye Eet al. Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy. J Am Coll Cardiol 2017;70:1216-1227. Go to original source... Go to PubMed...
  382. Cleland JG, Freemantle N, Erdmann E, et al. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail 2012;14:628-634.383 Barra S, Looi KL, Gajendragadkar PR, et al. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy. Europace 2016;18:1187-1193. Go to original source... Go to PubMed...
  383. Goldenberg I, Vyas AK, Hall WJ, et al.; MADIT-II Investigators. Risk stratification for primary implantation of a cardioverter--defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-296. Go to original source... Go to PubMed...
  384. Lumens J, Tayal B, Walmsley J, et al. Differentiating electromechanical from non-electrical substrates of mechanical discoordination to identify responders to
  385. Ploux S, Lumens J, Whinnett Z, et al. Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology. J Am Coll Cardiol 2013;61:2435-2443. Go to original source... Go to PubMed...
  386. Parsai C, Bijnens B, Sutherland GR, et al. Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of multiple mechanisms. Eur Heart J 2009;30:940-949. Go to original source... Go to PubMed...
  387. Adelstein EC, Tanaka H, Soman P, et al. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 2011;32:93-103. Go to original source... Go to PubMed...
  388. Taylor RJ, Umar F, Panting JR, et al. Left ventricular lead position, mechanical activation, and myocardial scar in relation to left ventricular reverse remodeling and clinical outcomes after cardiac resynchronization therapy: a feature-tracking and contrast-enhanced cardiovascular magnetic resonance study. Heart Rhythm 2016;13:481-489. Go to original source... Go to PubMed...
  389. Saba S, Marek J, Schwartzman D, et al. Echocardiography--guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail 2013;6:427-434. Go to original source... Go to PubMed...
  390. Stephansen C, Sommer A, Kronborg MB, et al. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial. Europace 2019;21:1369-1377. Go to original source... Go to PubMed...
  391. Delgado-Montero A, Tayal B, Goda A, et al. Additive prognostic value of echocardiographic global longitudinal and global circumferential strain to electrocardiographic criteria in patients with heart failure undergoing cardiac resynchronization therapy. Circ Cardiovasc Imaging 2016;9:e004241. Go to original source... Go to PubMed...
  392. Gorcsan J 3rd, Anderson CP, Tayal B, et al. Systolic stretch characterizes the electromechanical substrate responsive to cardiac resynchronization therapy. JACC Cardiovasc Imaging 2019;12:1741-1752. Go to original source... Go to PubMed...
  393. Khidir MJH, Abou R, Yilmaz D, et al. Prognostic value of global longitudinal strain in heart failure patients treated with cardiac resynchronization therapy. Heart Rhythm 2018;15:1533-1539. Go to original source... Go to PubMed...
  394. Donal E, Delgado V, Bucciarelli-Ducci C, et al.; EACVI Scientific Documents Committee. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2019;20:1075-1093. Go to original source... Go to PubMed...
  395. Bleeker GB, Kaandorp TA, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-976. Go to original source... Go to PubMed...
  396. Ypenburg C, Roes SD, Bleeker GB, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 2007;99:657-660. Go to original source... Go to PubMed...
  397. van der Bijl P, Khidir M, Ajmone Marsan N, et al. Effect of functional mitral regurgitation on outcome in patients receiving cardiac resynchronization therapy for heart failure. Am J Cardiol 2019;123:75-83. Go to original source... Go to PubMed...
  398. Leong DP, Hoke U, Delgado V, et al. Right ventricular function and survival following cardiac resynchronisation therapy. Heart 2013;99:722-728. Go to original source... Go to PubMed...
  399. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008;117:2608-2616. Go to original source... Go to PubMed...
  400. Beela AS, Unlu S, Duchenne J, et al. Assessment of mechanical dyssynchrony can improve the prognostic value of guideline- -based patient selection for cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 2019;20:66-74. Go to original source... Go to PubMed...
  401. Delgado V, Ypenburg C, van Bommel RJ, et al. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential,and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol 2008;51:1944-1952. Go to original source... Go to PubMed...
  402. Risum N, Tayal B, Hansen TF, et al. Identification of typical left bundle branch block contraction by strain echocardiography is additive to electrocardiography in prediction of long-term outcome after cardiac resynchronization therapy. J Am Coll Cardiol 2015;66:631-641. Go to original source... Go to PubMed...
  403. Leenders GE, Lumens J, Cramer MJ, et al. Septal deformation patterns delineate mechanical dyssynchrony and regional differences in contractility: analysis of patient data using a computer model. Circ Heart Fail 2012;5:87-96. Go to original source... Go to PubMed...
  404. Mafi-Rad M, Van't Sant J, Blaauw Y, et al. Regional left ventricular electrical activation and peak contraction are closely related in candidates for cardiac resynchronization therapy. JACC Clin Electrophysiol 2017;3:854-862. Go to original source... Go to PubMed...
  405. Maass AH, Vernooy K, Wijers SC, et al. Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) study. Europace 2018;20:e1-e10. Go to original source... Go to PubMed...
  406. van der Bijl P, Vo NM, Kostyukevich MV, et al. Prognostic implications of global, left ventricular myocardial work efficiency before cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 2019;20:1388-1394. Go to original source... Go to PubMed...
  407. Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012;59:1509-1518. Go to original source... Go to PubMed...
  408. Sommer A, Kronborg MB, Norgaard BL, et al. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial. Eur J Heart Fail 2016;18:1365-1374. Go to original source... Go to PubMed...
  409. Cikes M, Sanchez-Martinez S, Claggett B, et al. Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy. Eur J Heart Fail 2019;21:74-85. Go to original source... Go to PubMed...
  410. Di Biase L, Auricchio A, Mohanty P, et al. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace 2011;13:829-838. Go to original source... Go to PubMed...
  411. Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011;58:2183-2189. Go to original source... Go to PubMed...
  412. D'Ancona G, Ince H, Schillinger W, et al. Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry). Catheter Cardiovasc Interv 2019;94:755-763. Go to original source... Go to PubMed...
  413. Giaimo VL, Zappulla P, Cirasa A, et al. Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization. Pacing Clin Electrophysiol 2018;41:65-72. Go to original source... Go to PubMed...
  414. Seifert M, Schau T, Schoepp M, et al. MitraClip in CRT non--responders with severe mitral regurgitation. Int J Cardiol 2014;177:79-85. Go to original source... Go to PubMed...
  415. Obadia JF, Messika-Zeitoun D, Leurent G, et al.; MITRA-FR Investigators. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018;379:2297-2306. Go to original source... Go to PubMed...
  416. Stone GW, Lindenfeld J, Abraham WT, et al.; Mack MJ, COAPT Investigators. Transcatheter mitral‑valve repair in patients with heart failure. N Engl J Med 2018;379:2307-2318. Go to original source... Go to PubMed...
  417. Kaye GC, Linker NJ, Marwick TH, et al.; Protect-Pace trial investigators. Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study. Eur Heart J 2015;36:856-862. Go to original source... Go to PubMed...
  418. Leclercq C, Sadoul N, Mont L, et al.; SEPTAL CRT Study Investigators. Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study. Eur Heart J 2016;37:473-483. Go to original source... Go to PubMed...
  419. Hussain MA, Furuya-Kanamori L, Kaye G, et al. The Effect of right ventricular apical and nonapical pacing on the short-and long-term changes in left ventricular ejection fraction:a systematic review and meta-analysis of randomized- -controlled trials. Pacing Clin Electrophysiol 2015;38:1121-1136. Go to original source... Go to PubMed...
  420. Cano O, Andres A, Alonso P, et al. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads. Europace 2017;19:96-102. Go to original source... Go to PubMed...
  421. Sommer A, Kronborg MB, Norgaard BL, et al. Left and right ventricular lead positions are imprecisely determined by fluoroscopy in cardiac resynchronization therapy: a comparison with cardiac computed tomography. Europace 2014;16:1334-1341. Go to original source... Go to PubMed...
  422. Zanon F, Ellenbogen KA, Dandamudi G, et al. Permanent His-bundle pacing: a systematic literature review and meta-analysis. Europace 2018;20:1819-1826. Go to original source... Go to PubMed...
  423. Keene D, Arnold AD, Jastrzebski M, et al. His bundle pacing, learning curve, procedure characteristics, safety, and feasibility: insights from a large international observational study. J Cardiovasc Electrophysiol 2019;30:1984-1993. Go to original source... Go to PubMed...
  424. Vijayaraman P, Dandamudi G, Zanon F, et al. Permanent His bundle pacing: recommendations from a Multicenter His Bundle Pacing Collaborative Working Group for standardization of definitions, implant measurements, and follow-up. Heart Rhythm 2018;15:460-468. Go to original source... Go to PubMed...
  425. Burri H, Jastrzebski M, Vijayaraman P. ECG analysis for His bundle pacing at implantation and follow-up. JACC Clin Electrophysiol 2020;6:883-900. Go to original source... Go to PubMed...
  426. Teigeler T, Kolominsky J, Vo C, Shepard RK, et al. Intermediate term performance and safety of His bundle pacing leads: a single center experience. Heart Rhythm 2021;18:743-749. Go to original source... Go to PubMed...
  427. Vijayaraman P, Naperkowski A, Subzposh FA, et al. Permanent His-bundle pacing: long-term lead performance and clinical outcomes. Heart Rhythm 2018;15:696-702. Go to original source... Go to PubMed...
  428. Zanon F, Abdelrahman M, Marcantoni L, et al. Long term performance and safety of His bundle pacing: a multicenter experience. J Cardiovasc Electrophysiol 2019;30:1594-1601. Go to original source... Go to PubMed...
  429. Kirkfeldt RE, Johansen JB, Nohr EA, et al. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Heart Rhythm 2011;8:1622-1628. Go to original source... Go to PubMed...
  430. Starr N, Dayal N, Domenichini G, et al. Electrical parameters with His-bundle pacing: considerations for automated programming. Heart Rhythm 2019;16:1817-1824. Go to original source... Go to PubMed...
  431. Burri H, Keene D, Whinnett Z, et al. Device programming for His bundle pacing. Circ Arrhythm Electrophysiol 2019;12:e006816. Go to original source... Go to PubMed...
  432. Lustgarten DL, Sharma PS, Vijayaraman P. Troubleshooting and programming considerations for His bundle pacing. Heart Rhythm 2019;16:654-662. Go to original source... Go to PubMed...
  433. Vijayaraman P, Naperkowski A, Ellenbogen KA, Dandamudi G. Electrophysiologic insights into site of atrioventricular block. JACC Clin Electrophysiol 2015;1:571-581. Go to original source... Go to PubMed...
  434. Su L, Cai M, Wu S, et al. Long-term performance and risk factors analysis after permanent His-bundle pacing and atrioventricular node ablation in patients with atrial fibrillation and heart failure. Europace 2020;22:ii19-ii26. Go to original source... Go to PubMed...
  435. Narula OS. Longitudinal dissociation in the His bundle. Bundle branch block due to asynchronous conduction within the His bundle in man. Circulation 1977;56:996-1006. Go to original source... Go to PubMed...
  436. Upadhyay GA, Cherian T, Shatz DY, et al. Intracardiac delineation of septal conduction in left bundle-branch block patterns. Circulation 2019;139:1876-1888. Go to original source... Go to PubMed...
  437. Upadhyay GA, Vijayaraman P, Nayak HM, et al. His corrective pacing or biventricular pacing or cardiac resynchronization in heart failure. J Am Coll Cardiol 2019;74:157-159. Go to original source... Go to PubMed...
  438. Upadhyay GA, Vijayaraman P, Nayak HM, et al.; His-Sync Investigators. On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: a secondary analysis of the His-SYNC Pilot Trial. Heart Rhythm 2019;16:1797-1807. Go to original source... Go to PubMed...
  439. Lustgarten DL, Crespo EM, Arkhipova-Jenkins I, et al. His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: a crossover design comparison. Heart Rhythm 2015;12:1548-1557. Go to original source... Go to PubMed...
  440. Giraldi F, Cattadori G, Roberto M, et al. Long-term effectiveness of cardiac resynchronization therapy in heart failure patients with unfavorable cardiac veins anatomy comparison of surgical versus hemodynamic procedure. J Am Coll Cardiol 2011;58:483-490. Go to original source... Go to PubMed...
  441. Sharma PS, Naperkowski A, Bauch TD, et al. Permanent His bundle pacing for cardiac resynchronization therapy in patients with heart failure and right bundle branch block. Circ Arrhythm Electrophysiol 2018;11:e006613. Go to original source... Go to PubMed...
  442. Huang W, Chen X, Su L, et al. A beginner's guide to permanent left bundle branch pacing. Heart Rhythm 2019;16:1791-1796. Go to original source... Go to PubMed...
  443. Barba-Pichardo R, Manovel Sanchez A, Fernandez-Gomez JM, et al. Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator. Europace 2013;15:83-88. Go to original source... Go to PubMed...
  444. Zweerink A, Bakelants E, Stettler C, Burri H. Cryoablation vs. radiofrequency ablation of the atrioventricular node in patients with His-bundle pacing. Europace 2020;23:421-430. Go to original source... Go to PubMed...
  445. Valiton V, Graf D, Pruvot E, et al. Leadless pacing using the transcatheter pacing system (Micra TPS) in the real world: initial Swiss experience from the Romandie region. Europace 2019;21:275-280. Go to original source... Go to PubMed...
  446. Defaye P, Klug D, Anselme F, et al. Recommendations for the implantation of leadless pacemakers from the French Working Group on Cardiac Pacing and Electrophysiology of the French Society of Cardiology. Arch Cardiovasc Dis 2018;111:53-58. Go to original source... Go to PubMed...
  447. Leadless cardiac pacemaker therapy: design of pre-and post-market clinical studies. Recommendations from MHRA Expert Advisory Group. Version 3: Updated January 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/956252/Leadless-EAG-guidance.pdf (25 May 2021)
  448. Steinwender C, Khelae SK, Garweg C, et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study. JACC Clin Electrophysiol 2019;6:94-106. Go to original source... Go to PubMed...
  449. Beurskens NE, Tjong FV, Knops RE. End-of-life management of leadless cardiac pacemaker therapy. Arrhythm Electrophysiol Rev 2017;6:129-133. Go to original source... Go to PubMed...
  450. El-Chami MF, Johansen JB, Zaidi A, et al. Leadless pacemaker implant in patients with pre-existing infections: results from the Micra post-approval registry. J Cardiovasc Electrophysiol 2019;30:569-574. Go to original source... Go to PubMed...
  451. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 2003;348:933-940. Go to original source... Go to PubMed...
  452. Pejkovic B, Krajnc I, Anderhuber F, Kosutic D. Anatomical aspects of the arterial blood supply to the sinoatrial and atrioventricular nodes of the human heart. J Int Med Res 2008;36:691-698. Go to original source... Go to PubMed...
  453. Ritter WS, Atkins JM, Blomqvist CG, Mullins CB. Permanent pacing in patients with transient trifascicular block during acute myocardial infarction. Am J Cardiol 1976;38:205-208. Go to original source... Go to PubMed...
  454. Ginks WR, Sutton R, Oh W, Leatham A. Long-term prognosis after acute anterior infarction with atrioventricular block. Br Heart J 1977;39:186-189. Go to original source... Go to PubMed...
  455. Feigl D, Ashkenazy J, Kishon Y. Early and late atrioventricular block in acute inferior myocardial infarction. J Am Coll Cardiol 1984;4:35-38. Go to original source... Go to PubMed...
  456. Jim MH, Chan AO, Tse HF, et al. Clinical and angiographic findings of complete atrioventricular block in acute inferior myocardial infarction. Ann Acad Med Singapore 2010;39:185-190. Go to original source...
  457. Sutton R, Davies M. The conduction system in acute myocardial infarction complicated by heart block. Circulation 1968;38:987-992. Go to original source... Go to PubMed...
  458. Gang UJ, Hvelplund A, Pedersen S, et al. High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace 2012;14:1639-1645. Go to original source... Go to PubMed...
  459. Auffret V, Loirat A, Leurent G, et al. High-degree atrioventricular block complicating ST segment elevation myocardial infarction in the contemporary era. Heart 2016;102:40-49. Go to original source... Go to PubMed...
  460. Kim KH, Jeong MH, Ahn Y, et al.; Other Korea Acute Myocardial Infarction Registry Investigators. Differential clinical implications of high-degree atrioventricular blockcomplicating ST-segment elevation myocardial infarction according to the location of infarction in the era of primary percutaneous coronary intervention. Korean Circ J 2016;46:315-323. Go to original source... Go to PubMed...
  461. Kosmidou I, Redfors B, Dordi R, et al. Incidence, predictors, and outcomes of high-grade atrioventricular block in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). Am J Cardiol 2017;119:1295-1301. Go to original source... Go to PubMed...
  462. Singh SM, FitzGerald G, Yan AT, et al. High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. Eur Heart J 2015;36:976-983. Go to original source... Go to PubMed...
  463. Meine TJ, Al-Khatib SM, Alexander JH, et al. Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy. Am Heart J 2005;149:670-674. Go to original source... Go to PubMed...
  464. Hindman MC, Wagner GS, JaRo M, et al. The clinical significance of bundle branch block complicating acute myocardial infarction. 1. Clinical characteristics, hospital mortality, and one-year follow-up. Circulation 1978;58:679-688. Go to original source... Go to PubMed...
  465. Melgarejo-Moreno A, Galcera-Tomas J, Garcia-Alberola A, et al. Incidence, clinical characteristics, and prognostic significance of right bundle-branch block in acute myocardial infarction: a study in the thrombolytic era. Circulation 1997;96:1139-1144. Go to original source... Go to PubMed...
  466. Vivas D, Pérez-Vizcayno MJ, Hernandez-Antolin R, et al. Prognostic implications of bundle branch block in patients undergoing primary coronary angioplasty in the stent era. Am J Cardiol 2010;105:1276-1283. Go to original source... Go to PubMed...
  467. Xiong Y, Wang L, Liu W, et al. The prognostic significance of right bundle branch block: a meta-analysis of prospective cohort studies. Clin Cardiol 2015;38:604-613. Go to original source... Go to PubMed...
  468. Swart G, Brady WJ, DeBehnke DJ, et al. Acute myocardial infarction complicated by hemodynamically unstable bradyarrhythmia: prehospital and ED treatment with atropine. Am J Emerg Med 1999;17:647-652. Go to original source... Go to PubMed...
  469. Ibanez B, James S, Agewall S, et al.; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018;39:119-177. Go to original source... Go to PubMed...
  470. Watson RD, Glover DR, Page AJ, et al. The Birmingham Trial of permanent pacing in patients with intraventricular conduction disorders after acute myocardial infarction. Am Heart J 1984;108:496-501. Go to original source... Go to PubMed...
  471. Kusumoto FM, Calkins H, Boehmer J, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation 2014;130:94-125. Go to original source... Go to PubMed...
  472. Brodell GK, Cosgrove D, Schiavone W, et al. Cardiac rhythm and conduction disturbances in patients undergoing mitral valve surgery. Cleve Clin J Med 1991;58:397-399. Go to original source... Go to PubMed...
  473. Chung MK. Cardiac surgery: postoperative arrhythmias. Crit Care Med 2000;28:N136-N144. Go to original source... Go to PubMed...
  474. Jaeger FJ, Trohman RG, Brener S, Loop F. Permanent pacing following repeat cardiac valve surgery. Am J Cardiol 1994;74:505-507. Go to original source... Go to PubMed...
  475. Reade MC. Temporary epicardial pacing after cardiac surgery: a practical review. Part 1: general considerations in the management of epicardial pacing. Anaesthesia 2007;62:264-271. Go to original source... Go to PubMed...
  476. Reade MC. Temporary epicardial pacing after cardiac surgery: a practical review. Part 2: selection of epicardial pacing modes and troubleshooting. Anaesthesia 2007;62:364-373. Go to original source... Go to PubMed...
  477. Leyva F, Qiu T, McNulty D, et al. Long-term requirement for pacemaker implantation after cardiac valve replacement surgery. Heart Rhythm 2017;14:529-534. Go to original source... Go to PubMed...
  478. Merin O, Ilan M, Oren A, et al. Permanent pacemaker implantation following cardiac surgery: indications and long- -term follow-up. Pacing Clin Electrophysiol 2009;32:7-12. Go to original source... Go to PubMed...
  479. Glikson M, Dearani JA, Hyberger LK, et al. Indications, effectiveness, and long-term dependency in permanent pacing after cardiac surgery. Am J Cardiol 1997;80:1309-1313. Go to original source... Go to PubMed...
  480. Kim MH, Deeb GM, Eagle KA, et al. Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation. Am J Cardiol 2001;87:649-651, A10. Go to original source... Go to PubMed...
  481. Hill TE, Kiehl EL, Shrestha NK, et al. Predictors of permanent pacemaker requirement after cardiac surgery for infective endocarditis. Eur Heart J Acute Cardiovasc Care 2021;10:329-334. Go to original source... Go to PubMed...
  482. DiBiase A, Tse TM, Schnittger I, et al. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 1991;67:1385-1389. Go to original source... Go to PubMed...
  483. Melton IC, Gilligan DM, Wood MA, Ellenbogen KA. Optimal cardiac pacing after heart transplantation. Pacing Clin Electrophysiol 1999;22:1510-1527. Go to original source... Go to PubMed...
  484. Jacquet L, Ziady G, Stein K, et al. Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol 1990;16:832-837. Go to original source... Go to PubMed...
  485. Holt ND, McComb JM. Cardiac transplantation and pacemakers: when and what to implant. Card Electrophysiol Rev 2002;6:140-151. Go to original source... Go to PubMed...
  486. Burger H, Pecha S, Hakmi S, et al. Five-year follow-up of transvenous and epicardial left ventricular leads: experience with more than 1000 leads. Interact Cardiovasc Thorac Surg 2020;30:74-80. Go to original source... Go to PubMed...
  487. Noheria A, van Zyl M, Scott LR, et al. Single-site ventricular pacing via the coronary sinus in patients with tricuspid valve disease. Europace 2018;20:636-642. Go to original source... Go to PubMed...
  488. Sharma PS, Subzposh FA, Ellenbogen KA, Vijayaraman P. Permanent His-bundle pacing in patients with prosthetic cardiac valves. Heart Rhythm 2017;14:59-64. Go to original source... Go to PubMed...
  489. Martins RP, Galand V, Leclercq C, Daubert JC. Cardiac electronic implantable devices after tricuspid valve surgery. Heart Rhythm 2018;15:1081-1088. Go to original source... Go to PubMed...
  490. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic- -valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-1607. Go to original source... Go to PubMed...
  491. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-2198. Go to original source... Go to PubMed...
  492. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-1620. Go to original source... Go to PubMed...
  493. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic- -valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695-1705. Go to original source... Go to PubMed...
  494. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790-1798. Go to original source... Go to PubMed...
  495. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019;380:1706-1715. Go to original source... Go to PubMed...
  496. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321-1331. Go to original source... Go to PubMed...
  497. Barbash IM, Finkelstein A, Barsheshet A, et al. Outcomes of patients at estimated low, intermediate, and high risk undergoing transcatheter aortic valve implantation for aortic stenosis. Am J Cardiol 2015;116:1916-1922. Go to original source... Go to PubMed...
  498. Bekeredjian R, Szabo G, Balaban U, et al. Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J 2019;40:1323-1330. Go to original source... Go to PubMed...
  499. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-1715. Go to original source... Go to PubMed...
  500. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-2138. Go to original source... Go to PubMed...
  501. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-69. Go to original source... Go to PubMed...
  502. Werner N, Zahn R, Beckmann A, et al. Patients at intermediate surgical risk undergoing isolated interventional or surgical aortic valve implantation for severe symptomatic aortic valve stenosis. Circulation 2018;138:2611-2623. Go to original source... Go to PubMed...
  503. Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv 2016;9:2189-2199. Go to original source... Go to PubMed...
  504. Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, et al. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv 2016;9:e003635. Go to original source... Go to PubMed...
  505. Chamandi C, Barbanti M, Munoz-Garcia A, et al. Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018;11:301-310. Go to original source... Go to PubMed...
  506. Mohananey D, Jobanputra Y, Kumar A, et al. Clinical and echocardiographic outcomes following permanent pacemaker implantation after transcatheter aortic valve replacement: meta-analysis and meta-regression. Circ Cardiovasc Interv 2017;10:e005046. Go to original source... Go to PubMed...
  507. Ueshima D, Nai Fovino L, Mojoli M, et al. The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2018;92:E159-E167. Go to original source... Go to PubMed...
  508. Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 2014;129:1233-1243. Go to original source... Go to PubMed...
  509. Fujita B, Schmidt T, Bleiziffer S, et al.; Frerker C, GARY Executive Board. Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome. Eur J Cardiothorac Surg 2020;57:151-159. Go to original source... Go to PubMed...
  510. Zhang XH, Chen H, Siu CW, et al. New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function. J Cardiovasc Electrophysiol 2008;19:136-141. Go to original source... Go to PubMed...
  511. Dizon JM, Nazif TM, Hess PL, et al. Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 2015;101:1665-1671. Go to original source... Go to PubMed...
  512. Abramowitz Y, Kazuno Y, Chakravarty T, et al. Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement. Eur Heart J 2017;38:1194-1203. Go to original source... Go to PubMed...
  513. Al-Azzam F, Greason KL, Krittanawong C, et al. The influence of native aortic valve calcium and transcatheter valve oversize on the need for pacemaker implantation after transcatheter aortic valve insertion. J Thorac Cardiovasc Surg 2017;153:1056-1062.e1051. Go to original source... Go to PubMed...
  514. Bagur R, Rodés-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv 2012;5:540-551. Go to original source... Go to PubMed...
  515. Boerlage-Van Dijk K, Kooiman KM, Yong ZY, et al. Predictors and permanency of cardiac conduction disorders and necessity of pacing after transcatheter aortic valve implantation. Pacing Clin Electrophysiol 2014;37:1520-1529. Go to original source... Go to PubMed...
  516. Calvi V, Conti S, Pruiti GP, et al. Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis. J Interv Card Electrophysiol 2012;34:189-195. Go to original source... Go to PubMed...
  517. De Carlo M, Giannini C, Bedogni F, et al. Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantation. Am Heart J 2012;163:492-499. Go to original source... Go to PubMed...
  518. Fraccaro C, Buja G, Tarantini G, et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 2011;107:747-754. Go to original source... Go to PubMed...
  519. Gaede L, Kim WK, Liebetrau C, et al. Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol 2018;107:60-69. Go to original source... Go to PubMed...
  520. Guetta V, Goldenberg G, Segev A, et al. Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol 2011;108:1600-1605. Go to original source... Go to PubMed...
  521. Mangieri A, Lanzillo G, Bertoldi L, et al. Predictors of advanced conduction disturbances requiring a late (≥ 48 h) permanent pacemaker following transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018;11:1519-1526. Go to original source... Go to PubMed...
  522. Mauri V, Reimann A, Stern D, et al. Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv 2016;9:2200-2209. Go to original source... Go to PubMed...
  523. Mouillet G, Lellouche N, Yamamoto M, et al. Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve® devices: results from the FRANCE 2 Registry. Catheter Cardiovasc Interv 2015;86:E158-E166. Go to original source... Go to PubMed...
  524. Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv 2015;8:60-69. Go to original source... Go to PubMed...
  525. Siontis GC, Juni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 2014;64:129-140. Go to original source... Go to PubMed...
  526. van der Boon RM, Houthuizen P, Urena M, et al. Trends in the occurrence of new conduction abnormalities after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2015;85:E144-E152. Go to original source... Go to PubMed...
  527. Gonska B, Seeger J, Kessler M, et al. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve. Clin Res Cardiol 2017;106:590-597. Go to original source... Go to PubMed...
  528. Maeno Y, Abramowitz Y, Kawamori H, et al. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging 2017;10:1139-1147. Go to original source... Go to PubMed...
  529. Giustino G, Van der Boon RM, Molina-Martin de Nicolas J, et al. Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy. EuroIntervention 2016;12:1185-1193. Go to original source... Go to PubMed...
  530. Hamdan A, Guetta V, Klempfner R, et al. Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv 2015;8:1218-1228. Go to original source... Go to PubMed...
  531. Ledwoch J, Franke J, Gerckens U, et al. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry. Catheter Cardiovasc Interv 2013;82:E569-E577. Go to original source... Go to PubMed...
  532. Husser O, Pellegrini C, Kessler T, et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 2016;9:244-254. Go to original source... Go to PubMed...
  533. Toggweiler S, Stortecky S, Holy E, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv 2016;9:1269-1276. Go to original source... Go to PubMed...
  534. Urena M, Webb JG, Cheema A, et al. Impact of new-onset persistent left bundle branch block on late clinical outcomesin patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv 2014;7:128-136. Go to original source... Go to PubMed...
  535. Mouillet G, Lellouche N, Lim P, et al. Patients without prolonged QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block. Catheter Cardiovasc Interv 2013;81:882-887. Go to original source... Go to PubMed...
  536. Rodes-Cabau J, Urena M, Nombela-Franco L, et al. Arrhythmic burden as determined by ambulatory continuous cardiac monitoring in patients with new-onset persistent left bundle branch block following transcatheter aortic valve replacement: the MARE study. JACC Cardiovasc Interv 2018;11:1495-1505. Go to original source... Go to PubMed...
  537. Urena M, Webb JG, Eltchaninoff H, et al. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. J Am Coll Cardiol 2015;65:437-448. Go to original source... Go to PubMed...
  538. Auffret V, Puri R, Urena M, et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation 2017;136:1049-1069. Go to original source... Go to PubMed...
  539. Rogers T, Devraj M, Thomaides A, et al. Utility of invasive electrophysiology studies in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. Am J Cardiol 2018;121:1351-1357. Go to original source... Go to PubMed...
  540. Tovia-Brodie O, Ben-Haim Y, Joffe E, et al. The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI. J Interv Card Electrophysiol 2017;48:121-130. Go to original source... Go to PubMed...
  541. Rivard L, Schram G, Asgar A, et al. Electrocardiographic and electrophysiological predictors of atrioventricular block after transcatheter aortic valve replacement. Heart Rhythm 2015;12:321-329. Go to original source... Go to PubMed...
  542. Lilly SM, Deshmukh AJ, Epstein AE, et al. 2020 ACC Expert consensus decision pathway on management of conduction disturbances in patients undergoing transcatheter aortic valve replacement: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2020;76: 2391-2411. Go to original source... Go to PubMed...
  543. Rodés-Cabau J, Ellenbogen KA, Krahn AD, et al. Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC Scientific Expert Panel. J Am Coll Cardiol 2019;74:1086-1106. Go to original source... Go to PubMed...
  544. Costa G, Zappulla P, Barbanti M, et al. Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes. EuroIntervention 2019;15:875-883. Go to original source... Go to PubMed...
  545. Kaplan RM, Yadlapati A, Cantey EP, et al. Conduction recovery following pacemaker implantation after transcatheter aortic valve replacement. Pacing Clin Electrophysiol 2019;42:146-152. Go to original source... Go to PubMed...
  546. Junquera L, Freitas-Ferraz AB, Padron R, et al. Intraprocedural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances. Catheter Cardiovasc Interv 2019;95:982-990. Go to original source... Go to PubMed...
  547. Auffret V, Webb JG, Eltchaninoff H, et al. Clinical impact of baseline right bundle branch block in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 2017;10:1564-1574. Go to original source... Go to PubMed...
  548. Jorgensen TH, De Backer O, Gerds TA, et al. Immediate post-procedural 12-lead electrocardiography as predictor of late conduction defects after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018;11:1509-1518. Go to original source... Go to PubMed...
  549. Ream K, Sandhu A, Valle J, et al. Ambulatory rhythm monitoring to detect late high-grade atrioventricular block following transcatheter aortic valve replacement. J Am Coll Cardiol 2019;73:2538-2547. Go to original source... Go to PubMed...
  550. Kostopoulou A, Karyofillis P, Livanis E, et al. Permanent pacing after transcatheter aortic valve implantation of a CoreValve prosthesis as determined by electrocardiographic and electrophysiological predictors: a single-centre experience. Europace 2016;18:131-137. Go to original source... Go to PubMed...
  551. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts. Circulation 2006;113:2391-2397. Go to original source... Go to PubMed...
  552. Anand N. Chronotropic incompetence in young patients with late postoperative atrial flutter: a case-control study. Eur Heart J 2006;27:2069-2073. Go to original source... Go to PubMed...
  553. Fishberger SB, Wernovsky G, Gentles TL, et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg 1997;113:80-86. Go to original source... Go to PubMed...
  554. Gillette PC, Shannon C, Garson A, et al. Pacemaker treatment of sick sinus syndrome in children. J Am Coll Cardiol 1983;1:1325-1329. Go to original source... Go to PubMed...
  555. Kay R, Estioko M, Wiener I. Primary sick sinus syndrome as an indication for chronic pacemaker therapy in young adults: incidence, clinical features, and long-term evaluation. Am Heart J 1982;103:338-342. Go to original source... Go to PubMed...
  556. Ragonese P, Drago F, Guccione P, et al. Permanent overdrive atrial pacing in the chronic management of recurrent postoperative atrial reentrant tachycardia in patients with complex congenital heart disease. Pacing Clin Electrophysiol 1997;20:29172-923. Go to original source... Go to PubMed...
  557. Opic P, Yap SC, Van Kranenburg M, et al. Atrial-based pacing has no benefit over ventricular pacing in preventing atrial arrhythmias in adults with congenital heart disease. Europace 2013;15:1757-1762. Go to original source... Go to PubMed...
  558. Skanes AC, Krahn AD, Yee R, et al.; Canadian Trial of Physiologic Pacing. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol 2001;38:167-172. Go to original source... Go to PubMed...
  559. Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Circulation 2019;140:e333-e381. Go to original source... Go to PubMed...
  560. Kramer CC, Maldonado JR, Olson MD, et al. Safety and efficacy of atrial antitachycardia pacing in congenital heart disease. Heart Rhythm 2018;15:543-547. Go to original source... Go to PubMed...
  561. Stephenson EA, Casavant D, Tuzi J, et al.; ATTEST Investigators. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003;92:871-876. Go to original source... Go to PubMed...
  562. Jaeggi ET, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal, or childhood diagnosis of isolated congenital atrioventricular block: a single institution's experience of 30 years. ACC Current Journal Review 2002;11:95. Go to original source...
  563. Villain E, Coastedoat-Chalumeau N, Marijon E, et al. Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status. J Am Coll Cardiol 2006;48:1682-1687. Go to original source... Go to PubMed...
  564. Dewey RC, Capeless MA, Levy AM. Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block. N Engl J Med 1987;316:835-839. Go to original source... Go to PubMed...
  565. Karpawich PP, Gillette PC, Garson A Jr, et al. Congenital complete atrioventricular block: clinical and electrophysiologic predictors of need for pacemaker insertion. Am J Cardiol 1981;48:1098-1102. Go to original source... Go to PubMed...
  566. Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 1995;92:442-449. Go to original source... Go to PubMed...
  567. Beaufort-Krol GC, Schasfoort-van Leeuwen MJ, Stienstra Y, Bink-Boelkens MT. Longitudinal echocardiographic follow-up in children with congenital complete atrioventricular block. Pacing Clin Electrophysiol 2007;30:1339-1343. Go to original source... Go to PubMed...
  568. Breur JM, Udink Ten Cate FE, Kapusta L, et al. Pacemaker therapy in isolated congenital complete atrioventricular block. Pacing Clin Electrophysiol 2002;25:1685-1691. Go to original source... Go to PubMed...
  569. Bonatti V, Agnetti A, Squarcia U. Early and late postoperative complete heart block in pediatric patients submitted to open--heart surgery for congenital heart disease. Pediatr Med Chir 1998;20:181-186. Go to PubMed...
  570. Gross GJ, Chiu CC, Hamilton RM, et al. Natural history of postoperative heart block in congenital heart disease: implications for pacing intervention. Heart Rhythm 2006;3:601-604. Go to original source... Go to PubMed...
  571. Murphy D. Prognosis of complete atrioventricular dissociation in children after open-heart surgery. Lancet 1970;295:750-752. Go to original source... Go to PubMed...
  572. Krongrad E. Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation 1978;57:867-870. Go to original source... Go to PubMed...
  573. Villain E. Indications for pacing in patients with congenital heart disease. Pacing Clin Electrophysiol 2008;31(Suppl 1):S17-S20. Go to original source... Go to PubMed...
  574. Diller GP, Okonko D, Uebing A, et al. Cardiac resynchronization therapy for adult congenital heart disease patients with a systemic right ventricle: analysis of feasibility and review of early experience. Europace 2006;8:267-272. Go to original source... Go to PubMed...
  575. Rapezzi C, Arbustini E, Caforio ALP, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2012;34:1448-1458. Go to original source... Go to PubMed...
  576. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733-2779. Go to original source... Go to PubMed...
  577. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29:435-441. Go to original source... Go to PubMed...
  578. Kappenberger L, Linde C, Daubert C, et al. Pacing in hypertrophic obstructive cardiomyopathy: a randomized crossover study. Eur Heart J 1997;18:1249-1256. Go to original source... Go to PubMed...
  579. Maron BJ, Nishimura RA, McKenna WJ, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double‑blind, crossover study (M-PATHY). Circulation 1999;99:2927-2933. Go to original source... Go to PubMed...
  580. Slade AK, Sadoul N, Shapiro L, et al. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. Heart 1996;75:44-49. Go to original source... Go to PubMed...
  581. Megevand A, Ingles J, Richmond DR, Semsarian C. Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. Am J Cardiol 2005;95:991-993. Go to original source... Go to PubMed...
  582. Linde C, Gadler F, Kappenberger L, Ryden L. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol 1999;83:903-907. Go to original source... Go to PubMed...
  583. Ommen SR, Nishimura RA, Squires RW, et al. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. J Am Coll Cardiol 1999;34:191-196. Go to original source... Go to PubMed...
  584. Arnold AD, Howard JP, Chiew K, et al. Right ventricular pacing for hypertrophic obstructive cardiomyopathy: meta-analysis and meta-regression of clinical trials. Eur Heart J Qual Care Clin Outcomes 2019;5:321-333. Go to original source... Go to PubMed...
  585. Chang SM, Nagueh SF, Spencer WH 3rd, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 2003;42:296-300. Go to original source... Go to PubMed...
  586. Lawrenz T, Lieder F, Bartelsmeier M, et al. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2007;49:2356-2363. Go to original source... Go to PubMed...
  587. Topilski I, Sherez J, Keren G, Copperman I. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age. Am J Cardiol 2006;97:1769-1775. Go to original source... Go to PubMed...
  588. Cui H, Schaff HV, Nishimura RA, et al. Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2019;74:645-655. Go to original source... Go to PubMed...
  589. Rogers DP, Marazia S, Chow AW, et al. Effect of biventricular pacing on symptoms and cardiac remodelling in patientswith end-stage hypertrophic cardiomyopathy. Eur J Heart Fail 2008;10:507-513. Go to original source... Go to PubMed...
  590. Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive Summary: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020;142:e533-e557. Go to original source... Go to PubMed...
  591. Cappelli F, Morini S, Pieragnoli P, et al. Cardiac resynchronization therapy for end-stage hypertrophic cardiomyopathy: the need for disease-specific criteria. J Am Coll Cardiol 2018;71:464-466. Go to original source... Go to PubMed...
  592. Killu AM, Park JY, Sara JD, et al. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy. Europace 2018;20:82-88. Go to original source... Go to PubMed...
  593. Gu M, Jin H, Hua W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol 2017;14:238-244. Go to PubMed...
  594. Fruh A, Siem G, Holmstrom H, et al. The Jervell and Lange-Nielsen syndrome; atrial pacing combined with b-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome? Heart Rhythm 2016;13:2186-2192. Go to original source... Go to PubMed...
  595. Aziz PF, Tanel RE, Zelster IJ, et al. Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era. Heart Rhythm 2010;7:781-785. Go to original source... Go to PubMed...
  596. Feingold B, Mahle WT, Auerbach S, et al.; American Heart Association Pediatric Heart Failure Committee of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Radiology Intervention, Council on Functional Genomics Translational Biology, Stroke Council. Management of cardiac involvement associated with neuromuscular diseases: a Scientific Statement from the American Heart Association. Circulation 2017;136:e200-e231.
  597. Arbustini E, Di Toro A, Giuliani L, et al. Cardiac phenotypes in hereditary muscle disorders: JACC State-of-the-Art Review. J Am Coll Cardiol 2018;72:2485-2506. Go to original source... Go to PubMed...
  598. Groh WJ. Arrhythmias in the muscular dystrophies. Heart Rhythm 2012;9:1890-1895. Go to original source... Go to PubMed...
  599. Bhakta D, Shen C, Kron J, et al. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol 2011;22:1369-1375. Go to original source... Go to PubMed...
  600. Wahbi K, Meune C, Porcher R, et al. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. JAMA 2012;307:1292-1301. Go to original source... Go to PubMed...
  601. Lazarus A, Varin J, Babuty D, et al. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002;40:1645-1652. Go to original source... Go to PubMed...
  602. Laurent V, Pellieux S, Corcia P, et al. Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. Int J Cardiol 2011;150:54-58. Go to original source... Go to PubMed...
  603. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358:2688-2697. Go to original source... Go to PubMed...
  604. Ha AH, Tarnopolsky MA, Bergstra TG, et al. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II. Pacing Clin Electrophysiol 2012;35:1262-1269. Go to original source... Go to PubMed...
  605. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N Engl J Med 1999;341:1715-1724. Go to original source... Go to PubMed...
  606. Arbustini E, Pilotto A, Repetto A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002;39:981-990. Go to original source... Go to PubMed...
  607. Taylor MR, Fain PR, Sinagra G, et al.; Familial Dilated Cardiomyopathy Registry Research Group. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003;41:771-780. Go to original source... Go to PubMed...
  608. Sanna T. Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. Eur Heart J 2003;24:2227-2236. Go to original source... Go to PubMed...
  609. Haas J, Frese KS, Peil B, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2015;36:1123-1135. Go to original source... Go to PubMed...
  610. Gigli M, Merlo M, Graw SL, et al. Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J Am Coll Cardiol 2019;74:1480-1490. Go to original source... Go to PubMed...
  611. van Berlo JH, de Voogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) 2005;83:79-83. Go to original source... Go to PubMed...
  612. Meune C, Van Berlo JH, Anselme F, et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006;354:209-210. Go to original source... Go to PubMed...
  613. Anselme F, Moubarak G, Savoure A, et al. Implantable cardioverter‑defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. Heart Rhythm 2013;10:1492-1498. Go to original source... Go to PubMed...
  614. Hasselberg NE, Haland TF, Saberniak J, et al. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J 2018;39:853-860. Go to original source... Go to PubMed...
  615. Becane HM, Bonne G, Varnous S, et al. High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol 2000;23:1661-1666. Go to original source... Go to PubMed...
  616. Wahbi K, Ben Yaou R, Gandjbakhch E, et al. Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies. Circulation 2019;140:293-302. Go to original source... Go to PubMed...
  617. van Rijsingen IA, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers a European cohort study. J Am Coll Cardiol 2012;59:493-500. Go to original source... Go to PubMed...
  618. Kumar S, Baldinger SH, Gandjbakhch E, et al. Long-term arrhythmic and nonarrhythmic outcomes of lamin A/C mutation carriers. J Am Coll Cardiol 2016;68:2299-2307. Go to original source... Go to PubMed...
  619. Pasotti M, Klersy C, Pilotto A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 2008;52:1250-1260. Go to original source... Go to PubMed...
  620. Hasselberg NE, Edvardsen T, Petri H, et al. Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects. Europace 2014;16:563-571. Go to original source... Go to PubMed...
  621. Limongelli G, Tome-Esteban M, Dejthevaporn C, et al. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 2010;12:114-121. Go to original source... Go to PubMed...
  622. Anan R, Nakagawa M, Miyata M, et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995;91:955-961. Go to original source... Go to PubMed...
  623. Khambatta S, Nguyen DL, Beckman TJ, Wittich CM. Kearns- -Sayre syndrome: a case series of 35 adults and children. Int J Gen Med 2014;7:325-332. Go to original source... Go to PubMed...
  624. Kabunga P, Lau AK, Phan K, et al. Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy. Int J Cardiol 2015;181:303-310. Go to original source... Go to PubMed...
  625. Polak PE, Zijlstra F, Roelandt JR. Indications for pacemaker implantation in the Kearns-Sayre syndrome. Eur Heart J 1989;10:281-282. Go to original source... Go to PubMed...
  626. Nordenswan HK, Lehtonen J, Ekstrom K, e al. Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block. Circ Arrhythm Electrophysiol 2018;11:e006145. Go to original source... Go to PubMed...
  627. Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle‑aged adults. J Cardiovasc Electrophysiol 2014;25:875-881. Go to original source... Go to PubMed...
  628. Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997;134:382-386. Go to original source... Go to PubMed...
  629. Mankad P, Mitchell B, Birnie D, Kron J. Cardiac sarcoidosis. Curr Cardiol Rep 2019;21:152. Go to original source... Go to PubMed...
  630. Sadek MM, Yung D, Birnie DH, et al. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol 2013;29:1034-1041. Go to original source... Go to PubMed...
  631. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-1323. Go to original source... Go to PubMed...
  632. Schuller JL, Zipse M, Crawford T, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2012;23:925-929. Go to original source... Go to PubMed...
  633. Kron J, Sauer W, Schuller J, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace 2013;15:347-354. Go to original source... Go to PubMed...
  634. Birnie DH, Sauer WH, Judson MA. Consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart 2016;102:411-414. Go to original source... Go to PubMed...
  635. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al.; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165-3241. Go to original source... Go to PubMed...
  636. Tuzcu V, Gul EE, Erdem A, et al. Cardiac interventions in pregnant patients without fluoroscopy. Pediatr Cardiol 2015;36:1304-1307. Go to original source... Go to PubMed...
  637. Gudal M, Kervancioglu C, Oral D, et al. Permanent pacemaker implantation in a pregnant woman with the guidance of ECG and two-dimensional echocardiography. Pacing Clin Electrophysiol 1987;10:543-545. Go to original source... Go to PubMed...
  638. Traykov V, Bongiorni MG, Boriani G, et al. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association. Europace 2019;21:1270-1279. Go to original source... Go to PubMed...
  639. Klug D, Balde M, Pavin D, et al, People Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007;116:1349-1355. Go to original source... Go to PubMed...
  640. Enzler MJ, Berbari E, Osmon DR. Antimicrobial prophylaxis in adults. Mayo Clin Proc 2011;86:686-701. Go to original source... Go to PubMed...
  641. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 2015;17:767-777. Go to original source... Go to PubMed...
  642. Blomstrom-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections‑endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2020;41:2012-2032. Go to original source... Go to PubMed...
  643. de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009;2:29-34. Go to original source... Go to PubMed...
  644. Madadi S, Kafi M, Kheirkhah J, et al. Postoperative antibiotic prophylaxis in the prevention of cardiac implantable electronic device infection. Pacing Clin Electrophysiol 2019;42:161-165. Go to original source... Go to PubMed...
  645. Krahn AD, Longtin Y, Philippon F, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol 2018;72:3098-3109. Go to original source... Go to PubMed...
  646. Haines DE, Beheiry S, Akar JG, et al. Heart Rhythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm 2014;11:e9-e51. Go to original source... Go to PubMed...
  647. Mimoz O, Lucet J-C, Kerforne T, et al. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open‑label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 2015;386:2069-2077. Go to original source... Go to PubMed...
  648. Darouiche RO, Wall MJ Jr, Itani KM, et al. Chlorhexidine- -alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010;362:18-26. Go to original source... Go to PubMed...
  649. Essebag V, Verma A, Healey JS, et al.; BRUISE CONTROL Investigators. Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION Study. J Am Coll Cardiol 2016;67:1300-1308. Go to original source... Go to PubMed...
  650. Birnie DH, Healey JS, Wells GA, et al.; BRUISE CONTROL Investigators. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 2013;368:2084-2093. Go to original source... Go to PubMed...
  651. Malagu M, Trevisan F, Scalone A, et al. Frequency of 'pocket' hematoma in patients receiving vitamin K antagonist and antiplatelet therapy at the time of pacemaker or cardioverter defibrillator implantation (from the POCKET Study). Am J Cardiol 2017;119:1036-1040. Go to original source... Go to PubMed...
  652. Birnie DH, Healey JS, Wells GA, et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart J 2018;39:3973-3979. Go to original source... Go to PubMed...
  653. Kutinsky IB, Jarandilla R, Jewett M, Haines DE. Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 2010;3:312-318. Go to original source... Go to PubMed...
  654. Tompkins C, Cheng A, Dalal D, et al. Dual antiplatelet therapy and heparin 'bridging' significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 2010;55:2376-2382. Go to original source... Go to PubMed...
  655. Valgimigli M, Bueno H, Byrne RA, et al.; ESC Scientific Document Group, ESC Committee for Practice Guidelines, ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39:213-260. Go to original source... Go to PubMed...
  656. Rossini R, Musumeci G, Visconti LO, et al.; Italian Society of Invasive Cardiology, Italian Association of Hospital Cardiologists, Italian Society for Cardiac Surgery, Italian Society of Vascular and Endovascular Surgery, Italian Association of Hospital Surgeons, Italian Society of Surgery, Italian Society of Anaesthesia, Intensive Care Medicine, Lombard Society of Surgery, Italian Society of Maxillofacial Surgery, Italian Society of Reconstructive Plastic Surgery and Aesthetics, Italian Society of Thoracic Surgeons, Italian Society of Urology, Italian Society of Orthopaedics and Traumatology, Italian Society of Periodontology, Italian Federation of Scientific Societies of Digestive System Diseases Lombardia, Association of Obstetricians Gynaecologists Italian Hospital Lombardia, Society of Ophthalmology Lombardia. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention 2014;10:38-46. Go to original source... Go to PubMed...
  657. Essebag V, Healey JS, Joza J, et al. Effect of direct oral anticoagulants, warfarin, and antiplatelet agents on risk of device pocket hematoma: combined analysis of BRUISE CONTROL 1 and 2. Circ Arrhythm Electrophysiol 2019;12:e007545. Go to original source... Go to PubMed...
  658. Kirkfeldt RE, Johansen JB, Nohr EA, et al. Pneumothorax in cardiac pacing: a population-based cohort study of 28 860 Danish patients. Europace 2012;14:1132-1138. Go to original source... Go to PubMed...
  659. Liu P, Zhou Y-F, Yang P, et al. Optimized axillary vein technique versus subclavian vein technique in cardiovascular implantable electronic device implantation. Chin Med J 2016;129:2647-2651. Go to original source... Go to PubMed...
  660. Liccardo M, Nocerino P, Gaia S, Ciardiello C. Efficacy of ultrasound-guided axillary/subclavian venous approaches for pacemaker and defibrillator lead implantation: a randomized study. J Interv Card Electrophysiol 2018;51:153-160. Go to original source... Go to PubMed...
  661. Chan NY, Kwong NP, Cheong AP. Venous access and long-term pacemaker lead failure: comparing contrast-guided axillary vein puncture with subclavian puncture and cephalic cutdown. Europace 2017;19:1193-1197. Go to original source... Go to PubMed...
  662. Deharo JC, Bongiorni MG, Rozkovec A, et al. Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper. Europace 2012;14:124-134. Go to original source... Go to PubMed...
  663. Migliore F, Zorzi A, Bertaglia E, et al. Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol 2014;37:1602-1609. Go to original source... Go to PubMed...
  664. Segreti L, Di Cori A, Soldati E, et al. Major predictors of fibrous adherences in transvenous implantable cardioverter- -defibrillator lead extraction. Heart Rhythm 2014;11:2196-2201. Go to original source... Go to PubMed...
  665. Behar JM, Bostock J, Zhu Li AP, et al. Cardiac resynchronization therapy delivered via a multipolar left ventricular lead is associated with reduced mortality and elimination of phrenic nerve stimulation: long-term follow-up from a multicenter registry. J Cardiovasc Electrophysiol 2015;26:540-546. Go to original source... Go to PubMed...
  666. Forleo GB, Di Biase L, Panattoni G, et al. Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study. J Interv Card Electrophysiol 2015;42:59-66. Go to original source... Go to PubMed...
  667. Jackson KP, Faerestrand S, Philippon F, et al. Performance of a novel active fixation quadripolar left ventricular lead for cardiac resynchronization therapy: Attain Stability Quad Clinical Study results. J Cardiovasc Electrophysiol 2020;31:1147-1154. Go to original source... Go to PubMed...
  668. Ziacchi M, Diemberger I, Corzani A, et al. Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads. Sci Rep 2018;8:13262. Go to original source... Go to PubMed...
  669. Ziacchi M, Giannola G, Lunati M, et al. Bipolar active fixation left ventricular lead or quadripolar passive fixation lead? An Italian multicenter experience. J Cardiovasc Med (Hagerstown) 2019;20:192-200. Go to original source... Go to PubMed...
  670. Shimony A, Eisenberg MJ, Filion KB, Amit G. Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. Europace 2012;14:81-91. Go to original source... Go to PubMed...
  671. Ng ACT, Allman C, Vidaic J, et al. Long-term impact of right ventricular septal versus apical pacing on left ventricular synchrony and function in patients with second-or third-degree heart block. Am J Cardiol 2009;103:1096-1101. Go to original source... Go to PubMed...
  672. Hattori M, Naruse Y, Oginosawa Y, et al. Prognostic impact of lead tip position confirmed via computed tomography in patients with right ventricular septal pacing. Heart Rhythm 2019;16:921-927. Go to original source... Go to PubMed...
  673. Domenichini G, Sunthorn H, Fleury E, et al. Pacing of the interventricular septum versus the right ventricular apex: a prospective, randomized study. Eur J Intern Med 2012;23:621-627. Go to original source... Go to PubMed...
  674. Mahapatra S, Bybee KA, Bunch TJ, et al. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm 2005;2:907-911. Go to original source... Go to PubMed...
  675. Biffi M, de Zan G, Massaro G, et al. Is ventricular sensing always right, when it is left? Clin Cardiol 2018;41:1238-1245. Go to original source... Go to PubMed...
  676. Burri H, Muller H, Kobza R, et al. RIght VErsus Left Apical transvenous pacing for bradycardia: results of the RIVELA randomized study. Indian Pacing Electrophysiol J 2017;17:171-175. Go to original source... Go to PubMed...
  677. Tanabe K, Kotoda M, Nakashige D, et al. Sudden onset pacemaker-induced diaphragmatic twitching during general anesthesia. JA Clin Rep 2019;5:36. Go to original source... Go to PubMed...
  678. Khan AA, Nash A, Ring NJ, Marshall AJ. Right hemidiaphragmatic twitching: a complication of bipolar atrial pacing. Pacing Clin Electrophysiol 1997;20:1732-1733. Go to original source... Go to PubMed...
  679. Shali S, Su Y, Ge J. Interatrial septal pacing to suppress atrial fibrillation in patients with dual chamber pacemakers: a meta-analysis of randomized, controlled trials. Int J Cardiol 2016;219:421-427. Go to original source... Go to PubMed...
  680. Zhang L, Jiang H, Wang W, et al. Interatrial septum versus right atrial appendage pacing for prevention of atrial fibrillation: a meta‑analysis of randomized controlled trials. Herz 2018;43:438-446. Go to original source... Go to PubMed...
  681. Magnusson P, Wennstrom L, Kastberg R, Liv P. Placement Of Cardiac PacemaKEr Trial (POCKET) - rationale and design: a randomized controlled trial. Heart Int 2017;12:e8-e11. Go to original source... Go to PubMed...
  682. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol 1996;28:1278-1282. Go to original source... Go to PubMed...
  683. Lakshmanadoss U, Nuanez B, Kutinsky I, et al. Incidence of pocket infection postcardiac device implantation usingantibiotic versus saline solution for pocket irrigation. Pacing Clin Electrophysiol 2016;39:978-984. Go to original source... Go to PubMed...
  684. Mueller TC, Loos M, Haller B, et al. Intra-operative wound irrigation to reduce surgical site infections after abdominal surgery: a systematic review and meta-analysis. Langenbeck's Arch Surg 2015;400:167-181. Go to original source... Go to PubMed...
  685. Tarakji KG, Mittal S, Kennergren C, et al.; WRAP-IT Investigators. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 2019;380:1895-1905. Go to original source... Go to PubMed...
  686. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta- -analysis. Circulation 1998;97:1796-1801. Go to original source... Go to PubMed...
  687. Leyva F, Zegard A, Qiu T, et al. Cardiac resynchronization therapy using quadripolar versus non-quadripolar left ventricular leads programmed to biventricular pacing with single-site left ventricular pacing: impact on survival and heart failure hospitalization. J Am Heart Assoc 2017;6:e007026. Go to original source... Go to PubMed...
  688. Henrikson CA, Sohail MR, Acosta H, et al. Antibacterial envelope is associated with low infection rates after implantable cardioverter-defibrillator and cardiac resynchronization therapy device replacement: results of the Citadel and Centurion studies. JACC Clin Electrophysiol 2017;3:1158-1167. Go to original source... Go to PubMed...
  689. Ghanbari H, Phard WS, Al-Ameri H, et al. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices. Am J Cardiol 2012;110:1482-1488. Go to original source... Go to PubMed...
  690. Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of short-and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm 2012;9:728-735. Go to original source... Go to PubMed...
  691. Koneru JN, Jones PW, Hammill EF, et al. Risk factors and temporal trends of complications associated with transvenous implantable cardiac defibrillator leads. J Am Heart Assoc 2018;7:e007691. Go to original source... Go to PubMed...
  692. Ellenbogen KA, Hellkamp AS, Wilkoff BL, et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol 2003;92:740-741. Go to original source... Go to PubMed...
  693. Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol 1989;13:917-921. Go to original source... Go to PubMed...
  694. Ranasinghe I, Labrosciano C, Horton D, et al. Institutional variation in quality of cardiovascular implantable electronic device implantation: a cohort study. Ann Intern Med 2019;171:309-317. Go to original source... Go to PubMed...
  695. Poole JE, Gleva MJ, Mela T, et al.; REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 2010;122:1553-1561. Go to original source... Go to PubMed...
  696. Biffi M, Ammendola E, Menardi E, et al. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry. Europace 2019;21:1527-1536. Go to original source... Go to PubMed...
  697. Hosseini SM, Moazzami K, Rozen G, et al. Utilization and in- -hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013. Eur Heart J 2017;38:2122-2128. Go to original source... Go to PubMed...
  698. Zeitler EP, Patel D, Hasselblad V, et al. Complications from prophylactic replacement of cardiac implantable electronic device generators in response to United States Food and Drug Administration recall: a systematic review and meta‑analysis. Heart Rhythm 2015;12:1558-1564. Go to original source... Go to PubMed...
  699. Nowak B, Tasche K, Barnewold L, et al. Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme. Europace 2015;17:787-793. Go to original source... Go to PubMed...
  700. van Rees JB, de Bie MK, Thijssen J, et al. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J Am Coll Cardiol 2011;58:995-1000. Go to original source... Go to PubMed...
  701. Wiegand UK, Bode F, Bonnemeier H, et al. Long-term complication rates in ventricular, single lead VDD, and dual chamber pacing. Pacing Clin Electrophysiol 2003;26:1961-1969. Go to original source... Go to PubMed...
  702. Olsen T, Jorgensen OD, Nielsen JC, et al. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018). Eur Heart J 2019;40:1862-1869. Go to original source... Go to PubMed...
  703. Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011;58:1001-1006. Go to original source... Go to PubMed...
  704. Rennert-May E, Chew D, Lu S, et al. Epidemiology of cardiac implantable electronic device infections in the United States: a population-based cohort study. Heart Rhythm 2020;17:1125-1131. Go to original source... Go to PubMed...
  705. Ozcan C, Raunso J, Lamberts M, et al. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study. Europace 2017;19:1007-1014. Go to original source... Go to PubMed...
  706. Dai M, Cai C, Vaibhav V, et al. Trends of cardiovascular implantable electronic device infection in 3 decades: a population-based study. JACC Clin Electrophysiol 2019;5:1071-1080. Go to original source... Go to PubMed...
  707. Palmisano P, Accogli M, Zaccaria M, et al. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Europace 2013;15:531-540. Go to original source... Go to PubMed...
  708. Sohail MR, Henrikson CA, Braid-Forbes MJ, et al. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med 2011;171:1821-1828. Go to original source... Go to PubMed...
  709. Cantillon DJ, Dukkipati SR, Ip JH, et al. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Heart Rhythm 2018;15:1023-1030. Go to original source... Go to PubMed...
  710. Chahine J, Baranowski B, Tarakji K, et al. Cardiac venous injuries: procedural profiles and outcomes during left ventricular lead placement for cardiac resynchronization therapy. Heart Rhythm 2020;17:1298-1303. Go to original source... Go to PubMed...
  711. Seifert M, Schau T, Moeller V, et al. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy. Europace 2010;12:961-967. Go to original source... Go to PubMed...
  712. Biffi M, Moschini C, Bertini M, et al. Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2009;2:402-410. Go to original source... Go to PubMed...
  713. Rijal S, Wolfe J, Rattan R, et al. Lead related complications in quadripolar versus bipolar left ventricular leads. Indian Pacing Electrophysiol J 2017;17:37. Go to original source... Go to PubMed...
  714. Nichols CI, Vose JG. Incidence of bleeding-related complications during primary implantation and replacement of cardiac implantable electronic devices. J Am Heart Assoc 2017;6:e004263. Go to original source... Go to PubMed...
  715. Wiegand UKH, LeJeune D, Boguschewski F, Bonnemeier H, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 2004;126:1177-1186. Go to original source... Go to PubMed...
  716. Van De Heyning CM, Elbarasi E, Masiero S, et al. Prospective study of tricuspid regurgitation associated with permanent leads after cardiac rhythm device implantation. Can J Cardiol 2019;35:389-395. Go to original source... Go to PubMed...
  717. Cho MS, Kim J, Lee JB, et al. Incidence and predictors of moderate to severe tricuspid regurgitation after dual-chamber pacemaker implantation. Pacing Clin Electrophysiol 2019;42:85-92. Go to original source... Go to PubMed...
  718. Lee RC, Friedman SE, Kono AT, et al. Tricuspid regurgitation following implantation of endocardial leads: incidence and predictors. Pacing Clin Electrophysiol 2015;38:1267-1274. Go to original source... Go to PubMed...
  719. Link MS, Hellkamp AS, Estes NA 3rd, et al.; MOST Study Investigators. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular--based pacing in the Mode Selection Trial (MOST). J Am Coll Cardiol 2004;43:2066-2071. Go to original source... Go to PubMed...
  720. van Rooden CJ, Molhoek SG, Rosendaal FR, et al. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 2004;15:1258-1262. Go to original source... Go to PubMed...
  721. Da Costa SS, Scalabrini Neto A, Costa R, et al. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin Electrophysiol 2002;25:1301-1306. Go to original source... Go to PubMed...
  722. Ascoeta MS, Marijon E, Defaye P, et al.; DAI-PP Investigators. Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention. Heart Rhythm 2016;13:1045-1051. Go to original source... Go to PubMed...
  723. Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006;47:2493-2497. Go to original source... Go to PubMed...
  724. Sridhar AR, Yarlagadda V, Yeruva MR, et al. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study. Europace 2015;17:1548-1554. Go to original source... Go to PubMed...
  725. Habib G, Lancellotti P, Antunes MJ, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-3128. Go to original source... Go to PubMed...
  726. Clementy N, Carion PL, Leotoing L, et al. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study. Europace 2018;20:1974-1980. Go to original source... Go to PubMed...
  727. Rattanawong P, Kewcharoen J, Mekraksakit P, et al. Device infections in implantable cardioverter defibrillators versus permanent pacemakers: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 2019;30:1053-1065. Go to original source... Go to PubMed...
  728. Prutkin JM, Reynolds MR, Bao H, et al. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation 2014;130:1037-1043. Go to original source... Go to PubMed...
  729. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population‑based study. Arch Intern Med 2007;167:669-675. Go to original source... Go to PubMed...
  730. Chang JD, Manning WJ, Ebrille E, Zimetbaum PJ. Tricuspid valve dysfunction following pacemaker or cardioverter-defibrillator implantation. J Am Coll Cardiol 2017;69:2331-2341. Go to original source... Go to PubMed...
  731. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405-409. Go to original source... Go to PubMed...
  732. Hoke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart 2014;100:960-968. Go to original source... Go to PubMed...
  733. Mutlak D, Aronson D, Lessick J, et al. Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity? Chest 2009;135:115-121. Go to original source... Go to PubMed...
  734. Schleifer JW, Pislaru SV, Lin G, et al. Effect of ventricular pacing lead position on tricuspid regurgitation: a randomized prospective trial. Heart Rhythm 2018;15:1009-1016. Go to original source... Go to PubMed...
  735. Cheng Y, Gao H, Tang L, et al. Clinical utility of three--dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads. Echocardiography 2016;33:1689-1696. Go to original source... Go to PubMed...
  736. Beurskens NEG, Tjong FVY, de Bruin-Bon RHA, et al. Impact of leadless pacemaker therapy on cardiac and atrioventricular valve function through 12 months of follow-up. Circ Arrhythm Electrophysiol 2019;12:e007124. Go to original source... Go to PubMed...
  737. Addetia K, Harb SC, Hahn RT, et al. Cardiac implantable electronic device lead-induced tricuspid regurgitation. JACC Cardiovasc Imaging 2019;12:622-636. Go to original source... Go to PubMed...
  738. Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol 2019;74:2998-3008. Go to original source... Go to PubMed...
  739. Auricchio A, Gasparini M, Linde C, et al. Sex-related procedural aspects and complications in CRT Survey II: a multicenter European experience in 11,088 patients. JACC Clin Electrophysiol 2019;5:1048-1058. Go to original source... Go to PubMed...
  740. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996;74:511-544. Go to original source...
  741. Hendriks JM, de Wit R, Crijns HJ, et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J 2012;33:2692-2699. Go to original source... Go to PubMed...
  742. Gallagher C, Elliott AD, Wong CX, et al. Integrated care in atrial fibrillation: a systematic review and meta-analysis. Heart 2017;103:1947-1953. Go to original source... Go to PubMed...
  743. Wijtvliet E, Tieleman RG, van Gelder IC, et al.; RACE Investigators. Nurse-led vs. usual-care for atrial fibrillation. Eur Heart J 2020;41:634-641. Go to original source... Go to PubMed...
  744. Russo RJ, Costa HS, Silva PD, et al. Assessing the risks associated with MRI in patients with a pacemaker or defibrillator. N Engl J Med 2017;376:755-764. Go to original source... Go to PubMed...
  745. Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm 2017;14:e97-e153. Go to original source... Go to PubMed...
  746. Nazarian S, Hansford R, Rahsepar AA, et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med 2017;377:2555-2564. Go to original source... Go to PubMed...
  747. Balmer C, Gass M, Dave H, et al. Magnetic resonance imaging of patients with epicardial leads: in vitro evaluation of temperature changes at the lead tip. J Interv Card Electrophysiol 2019;56:321-326. Go to original source... Go to PubMed...
  748. Higgins JV, Gard JJ, Sheldon SH, et al. Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads. Pacing Clin Electrophysiol 2014;37:1284-1290. Go to original source... Go to PubMed...
  749. Padmanabhan D, Kella DK, Mehta R, et al. Safety of magnetic resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads. Heart Rhythm 2018;15:228-233. Go to original source... Go to PubMed...
  750. Horwood L, Attili A, Luba F, et al. Magnetic resonance imaging in patients with cardiac implanted electronic devices: focus on contraindications to magnetic resonance imaging protocols. Europace 2017;19:812-817. Go to original source... Go to PubMed...
  751. Vuorinen AM, Pakarinen S, Jaakkola I, et al. Clinical experience of magnetic resonance imaging in patients with cardiac pacing devices: unrestricted patient population. Acta Radiol 2019;60:1414-1421. Go to original source... Go to PubMed...
  752. Pulver AF, Puchalski MD, Bradley DJ, et al. Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with pacemakers. Pacing Clin Electrophysiol 2009;32:450-456. Go to original source... Go to PubMed...
  753. Wilkoff BL, Bello D, Taborsky M, et al.; EnRhythm MRI Sure- Scan Pacing System Study Investigators. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011;8:65-73. Go to original source... Go to PubMed...
  754. Shenthar J, Milasinovic G, Al Fagih A, et al. MRI scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results. Heart Rhythm 2015;12:759-765. Go to original source... Go to PubMed...
  755. Gimbel JR, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm 2013;10:685-691. Go to original source... Go to PubMed...
  756. Homsi R, Mellert F, Luechinger R, et al. Safety and feasibility of magnetic resonance imaging of the brain at 1.5 Tesla in patients with temporary transmyocardial pacing leads. Thorac Cardiovasc Surg 2019;67:86-91. Go to original source... Go to PubMed...
  757. Zaremba T, Jakobsen AR, Sogaard M, et al. Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study. Pacing Clin Electrophysiol 2015;38:343-356. Go to original source... Go to PubMed...
  758. Harms W, Budach W, Dunst J, et al.; Breast Cancer Expert Panel of the German Society of Radiation Oncology. DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Strahlenther Onkol 2016;192:199-208. Go to original source... Go to PubMed...
  759. Zecchin M, Severgnini M, Fiorentino A, et al. Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy: a consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM). Int J Cardiol 2018;255:175-183. Go to original source... Go to PubMed...
  760. Grant JD, Jensen GL, Tang C, et al. Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices: clinical incidence and predictors. JAMA Oncol 2015;1:624-632. Go to original source... Go to PubMed...
  761. Zaremba T, Jakobsen AR, Sogaard M, et al. Radiotherapy in patients with pacemakers and implantable cardioverter defibrillators: a literature review. Europace 2016;18:479-491. Go to original source... Go to PubMed...
  762. Hurkmans CW, Knegjens JL, Oei BS, et al.; Dutch Society of Radiotherapy Oncology. Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO). Radiat Oncol 2012;7:198. Go to original source... Go to PubMed...
  763. Gomez DR, Poenisch F, Pinnix CC, et al. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Biol Phys 2013;87:570-575. Go to original source... Go to PubMed...
  764. Tjong FVY, de Ruijter UW, Beurskens NEG, Knops RE. A comprehensive scoping review on transvenous temporary pacing therapy. Neth Heart J 2019;27:462-473. Go to original source... Go to PubMed...
  765. Hynes JK, Holmes DR Jr, Harrison CE. Five-year experience with temporary pacemaker therapy in the coronary care unit. Mayo Clin Proc 1983;58:122-126.
  766. Ferri LA, Farina A, Lenatti L, et al. Emergent transvenous cardiac pacing using ultrasound guidance: a prospective study versus the standard fluoroscopy-guided procedure. Eur Heart J Acute Cardiovasc Care 2016;5:125-129. Go to original source... Go to PubMed...
  767. Lang R, David D, Klein HO, et al. The use of the balloon-tipped floating catheter in temporary transvenous cardiac pacing. Pacing Clin Electrophysiol 1981;4:491-496. Go to original source... Go to PubMed...
  768. Ferguson JD, Banning AP, Bashir Y. Randomised trial of temporary cardiac pacing with semirigid and balloon-flotation electrode catheters. Lancet 1997; 349:18-83. Go to original source... Go to PubMed...
  769. Austin JL, Preis LK, Crampton RS, et al. Analysis of pacemaker malfunction and complications of temporary pacing in the coronary care unit. Am J Cardiol 1982;49:301-306. Go to original source... Go to PubMed...
  770. Hill PE. Complications of permanent transvenous cardiac pacing: a 14-year review of all transvenous pacemakers inserted at one community hospital. Pacing Clin Electrophysiol 1987;10:564-570. Go to original source... Go to PubMed...
  771. Murphy JJ. Current practice and complications of temporary transvenous cardiac pacing. BMJ 1996;312:11-34. Go to original source...
  772. Bjornstad CC, Gjertsen E, Thorup F, et al. Temporary cardiac pacemaker treatment in five Norwegian regional hospitals. Scand Cardiovasc J 2012;46:137-143. Go to original source... Go to PubMed...
  773. Lopez Ayerbe J, Villuendas Sabate R, Garcia C, et al. [Temporary pacemakers: current use and complications]. Rev Esp Cardiol 2004;57:1045-1052. Go to original source...
  774. Ng ACC, Lau JK, Chow V, et al. Outcomes of 4838 patients requiring temporary transvenous cardiac pacing: a statewide cohort study. Int J Cardiol 2018;271:98-104. Go to original source... Go to PubMed...
  775. Metkus TS, Schulman SP, Marine JE, Eid SM. Complications and outcomes of temporary transvenous pacing: an analysis of >360,000 patients from the National Inpatient Sample. Chest 2019;155:749-757. Go to PubMed...
  776. Lever N, Ferguson JD, Bashir Y, Channon KM. Prolonged temporary cardiac pacing using subcutaneous tunnelled active-fixation permanent pacing leads. Heart 2003;89:209-210. Go to original source... Go to PubMed...
  777. Rastan AJ, Doll N, Walther T, Mohr FW. Pacemaker dependent patients with device infection - a modified approach. Eur J Cardiothorac Surg 2005;27:1116-1118. Go to original source... Go to PubMed...
  778. Zei PC, Eckart RE, Epstein LM. Modified temporary cardiac pacing using transvenous active fixation leads and external re-sterilized pulse generators. J Am Coll Cardiol 2006;47:1487-1489. Go to original source... Go to PubMed...
  779. Kawata H, Pretorius V, Phan H, et al. Utility and safety of temporary pacing using active fixation leads and externalized re-usable permanent pacemakers after lead extraction. Europace 2013;15:1287-1291. Go to original source... Go to PubMed...
  780. Timothy PR, Rodeman BJ. Temporary pacemakers in critically ill patients: assessment and management strategies. AACN Clin Issues 2004;15:305-325. Go to original source... Go to PubMed...
  781. Abd Elaziz ME, Allama AM. Temporary epicardial pacing after valve replacement: incidence and predictors. Heart Surg Forum 2018;21:E049-E053. Go to original source... Go to PubMed...
  782. Lazarescu C, Mertes PM, Longrois D. [Temporary epicardial pacing following cardiac surgery: practical aspects]. Ann Fr Anesth Reanim 2013;32:592-601. Go to original source... Go to PubMed...
  783. Bektas F, Soyuncu S. The efficacy of transcutaneous cardiac pacing in ED. Am J Emerg Med 2016;34:2090-2093. Go to original source... Go to PubMed...
  784. Quast ABE, Beurskens NEG, Ebner A, et al. Feasibility of an entirely extracardiac, minimally invasive, temporary pacing system. Circ Arrhythm Electrophysiol 2019;12:e007182. Go to original source... Go to PubMed...
  785. Sherbino J, Verbeek PR, MacDonald RD, et al. Prehospital transcutaneous cardiac pacing for symptomatic bradycardia or bradyasystolic cardiac arrest: a systematic review. Resuscitation 2006;70:193-200. Go to original source... Go to PubMed...
  786. American Society of Anesthesiologists. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: an updated report by the American Society of Anesthesiologists task force on perioperative management of patients with cardiac implantable electronic devices. Anesthesiology 2011;114:247-261. Go to original source... Go to PubMed...
  787. Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm 2011;8:1114-1154. Go to original source... Go to PubMed...
  788. Healey JS, Merchant R, Simpson C, et al.; Canadian Cardiovascular Society, Canadian Anesthesiologists' Society, Canadian Heart Rhythm Society. Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. Can J Cardiol 2012;28:141-151. Go to original source... Go to PubMed...
  789. Boriani G, Fauchier L, Aguinaga L, et al.; ESC Scientific Document Group. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). Europace 2019;21:78. Go to original source... Go to PubMed...
  790. Schulman PM, Treggiari MM, Yanez ND, et al. Electromagnetic interference with protocolized electrosurgery dispersive electrode positioning in patients with implantable cardioverter defibrillators. Anesthesiology 2019;130:530-540. Go to original source... Go to PubMed...
  791. Gifford J, Larimer K, Thomas C, May P. ICD-ON Registry for perioperative management of CIEDs: most require no change. Pacing Clin Electrophysiol 2017;40:128-134. Go to original source... Go to PubMed...
  792. Heidbuchel H, Panhuyzen-Goedkoop N, Corrado D, et al.; Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil 2006;13:475-484. Go to original source... Go to PubMed...
  793. Lampert R. Managing with pacemakers and implantable cardioverter defibrillators. Circulation 2013;128:1576-1585. Go to original source... Go to PubMed...
  794. Pelliccia A, Fagard R, Bjornstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:1422-1445. Go to original source... Go to PubMed...
  795. Heidbuchel H, Adami PE, Antz M, et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart Rhythm Association (EHRA), both associations of the European Society of Cardiology. Eur J Prev Cardiol 2021;28:1539-1551. Go to original source... Go to PubMed...
  796. Pelliccia A, Sharma S, Gati S, et al.; ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2020;42:17-96. Go to original source... Go to PubMed...
  797. Lampert R, Olshansky B, Heidbuchel H, et al. Safety of sports for athletes with implantable cardioverter-defibrillators: long- -term results of a prospective multinational registry. Circulation 2017;135:2310-2312. Go to original source...
  798. Heidbuchel H, Arbelo E, D'Ascenzi F, et al. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators. Europace 2021;23:147-148. Go to original source... Go to PubMed...
  799. Hauser RG, Hayes DL, Kallinen LM, et al. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study. Heart Rhythm 2007;4:154-160. Go to original source... Go to PubMed...
  800. Merchant FM, Tejada T, Patel A, et al. Procedural outcomes and long-term survival associated with lead extraction in patients with abandoned leads. Heart Rhythm 2018;15:855-859. Go to original source... Go to PubMed...
  801. Diemberger I, Mazzotti A, Giulia MB, et al. From lead management to implanted patient management: systematic -review and meta-analysis of the last 15 years of experience in lead extraction. Expert Rev Med Devices 2013;10:551-573. Go to original source... Go to PubMed...
  802. Bongiorni MG, Kennergren C, Butter C, et al.; ELECTRa Investigators. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) registry of transvenous lead extraction outcomes. Eur Heart J 2017;38:2995-3005. Go to original source... Go to PubMed...
  803. Segreti L, Rinaldi CA, Claridge S, et al.; ELECTRa Investigators. Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry sub- -analysis. Europace 2019;21:645-654. Go to original source... Go to PubMed...
  804. Parthiban N, Esterman A, Mahajan R, et al. Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. J Am Coll Cardiol 2015;65:2591-2600. Go to original source... Go to PubMed...
  805. Garcia-Fernandez FJ, Osca Asensi J, Romero R, et al. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE). Eur Heart J 2019;40:1837-1846. Go to original source... Go to PubMed...
  806. Mabo P, Victor F, Bazin P, et al.; COMPAS Trial Investigators. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J 2012;33:1105-1111. Go to original source... Go to PubMed...
  807. Vogtmann T, Stiller S, Marek A, et al. Workload and usefulness of daily, centralized home monitoring for patients treated with CIEDs: results of the MoniC (Model Project Monitor Centre) prospective multicentre study. Europace 2013;15:219-226. Go to original source... Go to PubMed...
  808. Nielsen JC, Kautzner J, Casado-Arroyo R, et al. Remote monitoring of cardiac implanted electronic devices: legal requirements and ethical principles-ESC Regulatory Affairs Committee/EHRA joint task force report. Europace 2020;22:1742-1758. Go to original source... Go to PubMed...
  809. Perl S, Stiegler P, Rotman B, et al. Socio-economic effects and cost saving potential of remote patient monitoring (SAVEHM trial). Int J Cardiol 2013;169:402-407. Go to original source... Go to PubMed...
  810. Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace 2009;11:54-61. Go to original source... Go to PubMed...
  811. McCance T, McCormack B, Dewing J. An exploration of person--centredness in practice. Online J Issues Nurs 2011;16:1. Go to original source...
  812. Kitson A, Marshall A, Bassett K, Zeitz K. What are the core elements of patient-centred care? A narrative review and synthesis of the literature from health policy, medicine and nursing. J Adv Nurs 2013;69:4-15. Go to original source... Go to PubMed...
  813. Ekman I, Swedberg K, Taft C, et al. Person-centered care - ready for prime time. Eur J Cardiovasc Nurs 2011;10:248-251. Go to original source... Go to PubMed...
  814. Kiesler DJ, Auerbach SM. Optimal matches of patient preferences for information, decision-making and interpersonal behavior: evidence, models and interventions. Patient Educ Couns 2006;61:319-341. Go to original source... Go to PubMed...
  815. Alston C, Paget L, Halvorson G, et al. Communicating with Patients on Health Care Evidence. Washington, DC: Institute of Medicine of the National Academies; 2012. http://www.iom.edu/evidence.
  816. Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood) 2013;32:207-214. Go to original source... Go to PubMed...
  817. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44:681-692. Go to original source... Go to PubMed...
  818. Towle A, Godolphin W. Framework for teaching and learning informed shared decision making. BMJ 1999;319:766-771. Go to original source... Go to PubMed...
  819. Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns 2006;60:301-312. Go to original source... Go to PubMed...
  820. Pitcher D, Soar J, Hogg K, et al. Cardiovascular implanted electronic devices in people towards the end of life, during cardiopulmonary resuscitation and after death: guidance from the Resuscitation Council (UK), British Cardiovascular Society and National Council for Palliative Care. Heart 2016;102(Suppl 7):a1-a17. Go to original source... Go to PubMed...
  821. The SHARE Approach. https://www.ahrq.gov/health-literacy/professional-training/shared-decision/index.html (25 May 2021).
  822. International Patient Decision Aid Standards (IPDAS). IPDAS Collaboration Background Document, ipdas.ohri.ca/IPDAS_Background.pdf (25 May 2021).
  823. Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2017;4:Cd001431. Go to original source... Go to PubMed...
  824. De Oliveira GS Jr, McCarthy RJ, Wolf MS, Holl J. The impact of health literacy in the care of surgical patients: a qualitative systematic review. BMC Surg 2015;15:86. Go to original source... Go to PubMed...
  825. Berkman ND, Sheridan SL, Donahue KE, et al. Health literacy interventions and outcomes: an updated systematic review. Evid Rep Technol Assess (Full Report) 2011:1-941.
  826. Wolf A, Vella R, Fors A. The impact of person-centred care on patients' care experiences in relation to educational level after acute coronary syndrome: secondary outcome analysis of a randomised controlled trial. Eur J Cardiovasc Nurs 2019;18:299-308. Go to original source... Go to PubMed...
  827. Marcus C. Strategies for improving the quality of verbal patient and family education: a review of the literature and creation of the EDUCATE model. Health Psychol Behav Med 2014;2:482-495. Go to original source... Go to PubMed...
  828. Friedman AJ, Cosby R, Boyko S, et al. Effective teaching strategies and methods of delivery for patient education: a systematic review and practice guideline recommendations. J Cancer Educ 2011;26:12-21. Go to original source... Go to PubMed...
  829. Sustersic M, Gauchet A, Foote A, Bosson JL. How best to use and evaluate Patient Information Leaflets given during a consultation: a systematic review of literature reviews. Health Expect 2017;20:531-542. Go to original source... Go to PubMed...
  830. Elwyn G, Lloyd A, Joseph-Williams N, et al. Option grids: shared decision making made easier. Patient Educ Couns 2013;90:207-212. Go to original source... Go to PubMed...
  831. Dwamena F, Holmes-Rovner M, Gaulden CM, et al. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev 2012;12:Cd003267. Go to original source... Go to PubMed...
  832. Olsson LE, Jakobsson Ung E, Swedberg K, Ekman I. Efficacy of person-centred care as an intervention in controlled trials-a systematic review. J Clin Nurs 2013;22:456-465. Go to original source... Go to PubMed...
  833. McMillan SS, Kendall E, Sav A, et al. Patient-centered approaches to health care: a systematic review of randomized controlled trials. Med Care Res Rev 2013;70:567-596. Go to original source... Go to PubMed...
  834. Ekman I, Wolf A, Olsson LE, et al. Effects of person-centred care in patients with chronic heart failure: the PCCHF study. Eur Heart J 2012;33:1112-1119. Go to original source... Go to PubMed...
  835. Ulin K, Olsson LE, Wolf A, Ekman I. Person-centred care - an approach that improves the discharge process. Eur J Cardiovasc Nurs 2016;15:e19-e26. Go to original source... Go to PubMed...
  836. Dudas K, Olsson LE, Wolf A, et al. Uncertainty in illness among patients with chronic heart failure is less in person-centred care than in usual care. Eur J Cardiovasc Nurs 2013;12:521-528. Go to original source... Go to PubMed...
  837. Minchin M, Roland M, Richardson J, et al. Quality of care in the United Kingdom after removal of financial incentives. N Engl J Med 2018;379:948-957. Go to original source... Go to PubMed...
  838. Song Z, Ji Y, Safran DG, Chernew ME. Health care spending, utilization, and quality 8 years into global payment. N Engl J Med 2019;381:252-263. Go to original source... Go to PubMed...
  839. Aktaa S, Batra G, Wallentin L, et al. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. Eur Heart J Qual Care Clin Outcomes 2022;8:4-13. Go to original source... Go to PubMed...
  840. Arbelo E, Aktaa S, Bollmann A, et al. Quality indicators for the care and outcomes of adults with atrial fibrillation. Europace 2021;23:494-495. Go to original source... Go to PubMed...
  841. Collet JP, Thiele H, Barbato E, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021;42:1289-1367. Go to original source... Go to PubMed...
  842. Wallentin L, Gale CP, Maggioni A, et al. EuroHeart: European unified registries on heart care evaluation and randomized trials. Eur Heart J 2019;40:2745-2749. Go to original source... Go to PubMed...
  843. Zhang S, Gaiser S, Kolominsky-Rabas PL. Cardiac implant registries 20062016: a systematic review and summary of global experiences. BMJ Open 2018;8:e019039. Go to original source... Go to PubMed...
  844. Aktaa S, Abdin A, Arbelo E, et al. European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing Developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology. Europace 2022;24:165-172. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.